CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: omeprazole
Accession: CHEBI:7772
browse the term
Definition: A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
Synonyms: exact_synonym: rac-5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
related_synonym: 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; Antra; Audazol; Belmazol; Ceprandal; Danlox; Desec; Elgam; Emeproton; Gasec; Gastrimut; Indurgan; Inhibitron; Losec; OMEP; OMP; OMZ; Olit; Omapren; Omebeta; Prazidec; Procelac; Sanamidol; Ulceral; Ulcesep; Ultop; omeprazol; omeprazolum
xref: CAS:73590-58-6; DrugBank:DB00338; KEGG:C07324; KEGG:D00455
xref_mesh: MESH:D009853
xref: PMID:11060758; PMID:11208500; PMID:11210716; PMID:11304936; PMID:11321383; PMID:11395292; PMID:11404722; PMID:11459434; PMID:11568514; PMID:11700946; PMID:11774962; PMID:11807212; PMID:11851112; PMID:11903739; PMID:11962536; PMID:12072663; PMID:12135028; PMID:12235248; PMID:12495367; PMID:12683615; PMID:13680386; PMID:14616415; PMID:14708212; PMID:14725575; PMID:15004262; PMID:15125696; PMID:15586641; PMID:15598025; PMID:15684503; PMID:15707461; PMID:15774534; PMID:16080278; PMID:16129922; PMID:16259581; PMID:16276979; PMID:16380990; PMID:16386527; PMID:16397810; PMID:16440530; PMID:16998872; PMID:17049542; PMID:17384694; PMID:17532167; PMID:18294333; PMID:18366242; PMID:18416943; PMID:18448060; PMID:18498918; PMID:18520598; PMID:18571645; PMID:18616070; PMID:18793272; PMID:18818790; PMID:19150046; PMID:19166730; PMID:19176055; PMID:19236757; PMID:19327607; PMID:19383986; PMID:19434360; PMID:19470853; PMID:19517893; PMID:19746659; PMID:19796313; PMID:19801857; PMID:19937171; Patent:EP5129; Patent:US4255431; Patent:US5693818; Reaxys:3628192; VSDB:1827; Wikipedia:Omeprazole
G
Abca1
ATP-binding cassette, sub-family A member 1
increases expression
ISO
Omeprazole results in increased expression of ABCA1 mRNA
CTD
PMID:20060385
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
G
Abcb11
ATP-binding cassette, sub-family B member 11
decreases activity
ISO
Omeprazole results in decreased activity of ABCB11 protein
CTD
PMID:20829430
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
affects expression multiple interactions
ISO
Omeprazole affects the expression of ABCB1A mRNA Omeprazole promotes the reaction [Cisplatin results in increased expression of ABCB1 protein] Omeprazole promotes the reaction [Cisplatin results in increased expression of ABCB1A protein]
CTD
PMID:19483382 PMID:30452898
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcb4
ATP-binding cassette, sub-family B member 4
decreases expression
ISO
Omeprazole results in decreased expression of ABCB4 mRNA
CTD
PMID:12040753
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
G
Abcc2
ATP-binding cassette, sub-family member 2
multiple interactions
ISO
[Omeprazole results in increased susceptibility to Cisplatin] which results in decreased expression of ABCC2 protein
CTD
PMID:35447140
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcc3
ATP-binding cassette, sub-family C member 3
increases expression
ISO
Omeprazole results in increased expression of ABCC3 mRNA
CTD
PMID:19118567
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
G
Abcc6
ATP-binding cassette, sub-family C member 6
affects expression
ISO
Omeprazole affects the expression of ABCC6 mRNA
CTD
PMID:19483382
NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
G
Abcg2
ATP binding cassette subfamily G member 2 (Junior blood group)
increases expression multiple interactions
ISO
Omeprazole results in increased expression of ABCG2 mRNA alternative form; Omeprazole results in increased expression of ABCG2 protein Omeprazole inhibits the reaction [ABCG2 protein results in increased transport of lucifer yellow]
CTD
PMID:20804740 PMID:31348918
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
G
Abcg5
ATP binding cassette subfamily G member 5
affects expression
ISO
Omeprazole affects the expression of ABCG5 mRNA
CTD
PMID:19483382
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
G
Abhd1
abhydrolase domain containing 1
affects expression
ISO
Omeprazole affects the expression of ABHD1 mRNA
CTD
PMID:19483382
NCBI chr 5:31,107,410...31,112,439
Ensembl chr 5:31,107,410...31,112,435
G
Abhd14b
abhydrolase domain containing 14b
affects expression
ISO
Omeprazole affects the expression of ABHD14B mRNA
CTD
PMID:19483382
NCBI chr 9:106,324,936...106,330,122
Ensembl chr 9:106,324,658...106,330,122
G
Abhd17a
abhydrolase domain containing 17A
affects expression
ISO
Omeprazole affects the expression of ABHD17A mRNA
CTD
PMID:19483382
NCBI chr10:80,419,483...80,426,199
Ensembl chr10:80,419,488...80,426,175
G
Acaca
acetyl-Coenzyme A carboxylase alpha
affects expression
ISO
Omeprazole affects the expression of ACACA mRNA
CTD
PMID:19483382
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
G
Acadl
acyl-Coenzyme A dehydrogenase, long-chain
affects expression
ISO
Omeprazole affects the expression of ACADL mRNA
CTD
PMID:19483382
NCBI chr 1:66,869,998...66,902,468
Ensembl chr 1:66,869,998...66,902,436
G
Ace2
angiotensin converting enzyme 2
decreases expression
ISO
Omeprazole results in decreased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Aco1
aconitase 1
affects expression
ISO
Omeprazole affects the expression of ACO1 mRNA
CTD
PMID:19483382
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
G
Aco2
aconitase 2, mitochondrial
affects expression
ISO
Omeprazole affects the expression of ACO2 mRNA
CTD
PMID:19483382
NCBI chr15:81,756,664...81,799,338
Ensembl chr15:81,756,510...81,799,334
G
Acot12
acyl-CoA thioesterase 12
affects expression
ISO
Omeprazole affects the expression of ACOT12 mRNA
CTD
PMID:19483382
NCBI chr13:91,889,635...91,934,271
Ensembl chr13:91,889,631...91,934,267
G
Acot4
acyl-CoA thioesterase 4
affects expression
ISO
Omeprazole affects the expression of ACOT4 mRNA
CTD
PMID:19483382
NCBI chr12:84,084,028...84,091,497
Ensembl chr12:84,085,153...84,095,375
G
Adam15
ADAM metallopeptidase domain 15
affects expression
ISO
Omeprazole affects the expression of ADAM15 mRNA
CTD
PMID:19483382
NCBI chr 3:89,246,947...89,257,589
Ensembl chr 3:89,245,849...89,257,303
G
Add1
adducin 1
affects expression
ISO
Omeprazole affects the expression of ADD1 mRNA
CTD
PMID:19483382
NCBI chr 5:34,731,008...34,789,652
Ensembl chr 5:34,731,008...34,789,652
G
Adh1
alcohol dehydrogenase 1 (class I)
decreases expression
ISO
Omeprazole results in decreased expression of ADH1C mRNA
CTD
PMID:12040753
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
affects expression
ISO
Omeprazole affects the expression of ADH4 mRNA
CTD
PMID:19483382
NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
G
Adtrp
androgen dependent TFPI regulating protein
affects expression
ISO
Omeprazole affects the expression of ADTRP mRNA
CTD
PMID:19483382
NCBI chr13:41,916,621...42,001,092
Ensembl chr13:41,916,624...42,001,160
G
Afm
afamin
affects expression
ISO
Omeprazole affects the expression of AFM mRNA
CTD
PMID:19483382
NCBI chr 5:90,666,808...90,701,403
Ensembl chr 5:90,666,791...90,701,402
G
Agt
angiotensinogen
affects expression
ISO
Omeprazole affects the expression of AGT mRNA
CTD
PMID:19483382
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Agtr1a
angiotensin II receptor, type 1a
affects expression
ISO
Omeprazole affects the expression of AGTR1A mRNA
CTD
PMID:19483382
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Ahr
aryl-hydrocarbon receptor
multiple interactions increases response to substance affects localization decreases expression increases expression increases activity decreases activity
ISO EXP
AG-879 inhibits the reaction [Omeprazole results in increased activity of AHR protein]; AHR protein affects the reaction [Omeprazole results in decreased expression of CXCR4 mRNA]; AHR protein affects the reaction [Omeprazole results in increased expression of HAMP mRNA]; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA]; AHR protein mutant form inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of AHR mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of CYP1A1 mRNA]; BMX mRNA affects the reaction [Omeprazole results in increased activity of AHR protein]; Omeprazole binds to and results in increased activity of AHR protein; Omeprazole promotes the reaction [AHR protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter]; omeprazole sulfide inhibits the reaction [Omeprazole results in increased activity of AHR protein]; Puromycin inhibits the reaction [Omeprazole results in increased expression of AHR protein] [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; AHR protein promotes the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Omeprazole affects the localization of [ARNT protein co-treated with AHR protein] AHR protein results in increased susceptibility to Omeprazole Omeprazole affects the localization of AHR protein Omeprazole results in decreased activity of AHR protein
CTD
PMID:9139728 PMID:9395520 PMID:14742684 PMID:16109480 PMID:20171196 PMID:21703235 PMID:21861773 PMID:21924250 PMID:22687989 PMID:23850985 PMID:25797602 PMID:25826687 PMID:26187274 PMID:26272953 PMID:31669099 More...
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Akr1a1
aldo-keto reductase family 1, member A1
affects expression
ISO
Omeprazole affects the expression of AKR1A1 mRNA
CTD
PMID:19483382
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr7a5
aldo-keto reductase family 7, member A5
affects expression
ISO
Omeprazole affects the expression of AKR7A2 mRNA
CTD
PMID:19483382
NCBI chr 4:139,038,005...139,046,097
Ensembl chr 4:139,038,055...139,045,737
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
affects expression multiple interactions
ISO
Omeprazole affects the expression of ALDH1A1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA
CTD
PMID:19483382 PMID:22687989
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
G
Aldh1a3
aldehyde dehydrogenase family 1, subfamily A3
increases expression
ISO
Omeprazole results in increased expression of ALDH1A3 mRNA
CTD
PMID:12040753
NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
affects expression
ISO
Omeprazole affects the expression of ALDH2 mRNA
CTD
PMID:19483382
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Aldh3a1
aldehyde dehydrogenase family 3, subfamily A1
increases expression
ISO
Omeprazole results in increased expression of ALDH3A1 mRNA
CTD
PMID:12040753
NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247
G
Alkbh7
alkB homolog 7
affects expression
ISO
Omeprazole affects the expression of ALKBH7 mRNA
CTD
PMID:19483382
NCBI chr17:57,304,339...57,306,340
Ensembl chr17:57,304,339...57,306,322
G
Ankrd40
ankyrin repeat domain 40
increases expression
ISO
Omeprazole results in increased expression of TMPRSS2 mRNA
CTD
PMID:32808185
NCBI chr11:94,218,827...94,232,673
Ensembl chr11:94,218,827...94,232,667
G
Ap2m1
adaptor-related protein complex 2, mu 1 subunit
affects expression
ISO
Omeprazole affects the expression of AP2M1 mRNA
CTD
PMID:19483382
NCBI chr16:20,354,230...20,363,659
Ensembl chr16:20,354,228...20,363,659
G
Apcs
amyloid P component, serum
affects expression
ISO
Omeprazole affects the expression of APCS mRNA
CTD
PMID:19483382
NCBI chr 1:172,721,528...172,722,516
Ensembl chr 1:172,721,528...172,722,608
G
Apoa4
apolipoprotein A-IV
affects expression
ISO
Omeprazole affects the expression of APOA4 mRNA
CTD
PMID:19483382
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
Apoh
apolipoprotein H
affects expression
ISO
Omeprazole affects the expression of APOH mRNA
CTD
PMID:19483382
NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222
G
Apool
apolipoprotein O-like
affects expression
ISO
Omeprazole affects the expression of APOOL mRNA
CTD
PMID:19483382
NCBI chr X:111,221,049...111,282,452
Ensembl chr X:111,221,031...111,282,452
G
Arg1
arginase, liver
affects expression
ISO
Omeprazole affects the expression of ARG1 mRNA
CTD
PMID:19483382
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Arl6ip1
ADP-ribosylation factor-like 6 interacting protein 1
affects expression
ISO
Omeprazole affects the expression of ARL6IP1 mRNA
CTD
PMID:19483382
NCBI chr 7:117,718,113...117,728,848
Ensembl chr 7:117,718,114...117,728,885
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions affects localization
ISO
Omeprazole promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1B1 promoter] Omeprazole affects the localization of [ARNT protein co-treated with AHR protein] Omeprazole affects the localization of ARNT protein
CTD
PMID:9395520 PMID:21703235 PMID:25826687
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
G
Asgr2
asialoglycoprotein receptor 2
affects expression
ISO
Omeprazole affects the expression of ASGR2 mRNA
CTD
PMID:19483382
NCBI chr11:69,983,470...69,997,013
Ensembl chr11:69,983,470...69,997,013
G
Atf5
activating transcription factor 5
affects expression
ISO
Omeprazole affects the expression of ATF5 mRNA
CTD
PMID:19483382
NCBI chr 7:44,461,680...44,466,082
Ensembl chr 7:44,461,680...44,466,082
G
Atp5f1e
ATP synthase F1 subunit epsilon
affects expression
ISO
Omeprazole affects the expression of ATP5F1E mRNA
CTD
PMID:19483382
NCBI chr 2:174,302,868...174,305,894
Ensembl chr 2:174,302,865...174,305,898
G
Atp6ap2
ATPase, H+ transporting, lysosomal accessory protein 2
affects expression
ISO
Omeprazole affects the expression of ATP6AP2 mRNA
CTD
PMID:19483382
NCBI chr X:12,453,998...12,483,290
Ensembl chr X:12,454,040...12,483,288
G
Atp6v1a
ATPase, H+ transporting, lysosomal V1 subunit A
affects expression
ISO
Omeprazole affects the expression of ATP6V1A mRNA
CTD
PMID:19483382
NCBI chr16:43,905,765...43,960,055
Ensembl chr16:43,905,765...43,960,068
G
Atp6v1f
ATPase, H+ transporting, lysosomal V1 subunit F
affects expression
ISO
Omeprazole affects the expression of ATP6V1F mRNA
CTD
PMID:19483382
NCBI chr 6:29,467,782...29,470,508
Ensembl chr 6:29,467,717...29,470,511
G
Atp7a
ATPase, copper transporting, alpha polypeptide
multiple interactions
ISO EXP
Omeprazole inhibits the reaction [ATP7A protein results in increased activity of TYR protein] Omeprazole inhibits the reaction [Copper affects the localization of ATP7A protein]; Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein]
CTD
PMID:25337692
NCBI chr X:105,070,830...105,171,766
Ensembl chr X:105,070,882...105,168,532
G
Baat
bile acid-Coenzyme A: amino acid N-acyltransferase
affects expression
ISO
Omeprazole affects the expression of BAAT mRNA
CTD
PMID:19483382
NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557
G
Bax
BCL2-associated X protein
multiple interactions
ISO
Omeprazole inhibits the reaction [Cisplatin results in increased expression of BAX protein]
CTD
PMID:30452898
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
multiple interactions
ISO
Omeprazole inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]
CTD
PMID:30452898
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl6b
B cell CLL/lymphoma 6, member B
affects expression
ISO
Omeprazole affects the expression of BCL6B mRNA
CTD
PMID:19483382
NCBI chr11:70,114,953...70,120,624
Ensembl chr11:70,114,954...70,120,624
G
Bltp3b
bridge-like lipid transfer protein family member 3B
affects expression
ISO
Omeprazole affects the expression of BLTP3B mRNA
CTD
PMID:19483382
NCBI chr10:89,580,830...89,655,753
Ensembl chr10:89,580,853...89,655,733
G
Bmf
BCL2 modifying factor
affects expression
ISO
Omeprazole affects the expression of BMF mRNA
CTD
PMID:19483382
NCBI chr 2:118,359,238...118,385,240
Ensembl chr 2:118,359,238...118,380,168
G
Bmx
BMX non-receptor tyrosine kinase
multiple interactions
ISO
BMX mRNA affects the reaction [Omeprazole results in increased activity of AHR protein]
CTD
PMID:21861773
NCBI chr X:162,975,838...163,041,189
Ensembl chr X:162,975,838...163,041,189
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
affects expression
ISO
Omeprazole affects the expression of BNIP3 mRNA
CTD
PMID:19483382
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
Btf3
basic transcription factor 3
affects expression
ISO
Omeprazole affects the expression of BTF3 mRNA
CTD
PMID:19483382
NCBI chr13:98,446,405...98,453,514
Ensembl chr13:98,446,404...98,453,514
G
C1qa
complement component 1, q subcomponent, alpha polypeptide
decreases expression
ISO
Omeprazole results in decreased expression of C1QA mRNA
CTD
PMID:25626140
NCBI chr 4:136,623,227...136,626,155
Ensembl chr 4:136,623,228...136,626,114
G
C1qbp
complement component 1, q subcomponent binding protein
affects expression
ISO
Omeprazole affects the expression of C1QBP mRNA
CTD
PMID:19483382
NCBI chr11:70,868,672...70,873,852
Ensembl chr11:70,868,662...70,873,852
G
C1qc
complement component 1, q subcomponent, C chain
decreases expression
ISO
Omeprazole results in decreased expression of C1QC mRNA
CTD
PMID:25626140
NCBI chr 4:136,617,115...136,620,225
Ensembl chr 4:136,617,115...136,620,376
G
C1s1
complement component 1, s subcomponent 1
affects expression
ISO
Omeprazole affects the expression of C1S mRNA
CTD
PMID:19483382
NCBI chr 6:124,507,303...124,519,340
Ensembl chr 6:124,507,304...124,519,318
G
C2cd2
C2 calcium-dependent domain containing 2
affects expression
ISO
Omeprazole affects the expression of C2CD2 mRNA
CTD
PMID:19483382
NCBI chr16:97,656,409...97,727,248
Ensembl chr16:97,656,409...97,763,798
G
C7
complement component 7
affects expression
ISO
Omeprazole affects the expression of C7 mRNA
CTD
PMID:19483382
NCBI chr15:5,017,232...5,093,230
Ensembl chr15:5,018,244...5,093,222
G
C8b
complement component 8, beta polypeptide
affects expression
ISO
Omeprazole affects the expression of C8B mRNA
CTD
PMID:19483382
NCBI chr 4:104,623,514...104,661,745
Ensembl chr 4:104,623,514...104,661,745
G
Cadps2
Ca2+-dependent activator protein for secretion 2
affects expression
ISO
Omeprazole affects the expression of CADPS2 mRNA
CTD
PMID:19483382
NCBI chr 6:23,262,765...23,840,662
Ensembl chr 6:23,262,772...23,839,420
G
Caprin1
cell cycle associated protein 1
affects expression
ISO
Omeprazole affects the expression of CAPRIN1 mRNA
CTD
PMID:19483382
NCBI chr 2:103,593,292...103,627,946
Ensembl chr 2:103,593,286...103,627,994
G
Car2
carbonic anhydrase 2
affects expression
ISO
Omeprazole affects the expression of CA2 mRNA
CTD
PMID:19483382
NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830
G
Car3
carbonic anhydrase 3
affects expression
ISO
Omeprazole affects the expression of CAR3 mRNA
CTD
PMID:19483382
NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
G
Casp3
caspase 3
increases activity increases cleavage affects expression multiple interactions
ISO
Omeprazole analog results in increased activity of CASP3 protein; Omeprazole results in increased activity of CASP3 protein Omeprazole results in increased cleavage of CASP3 protein Omeprazole affects the expression of CASP3 mRNA Omeprazole inhibits the reaction [Ethanol results in increased activity of CASP3 protein]; Omeprazole inhibits the reaction [Ethanol results in increased expression of CASP3 mRNA]; Omeprazole inhibits the reaction [Indomethacin results in increased activity of CASP3 protein] Omeprazole inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]
CTD
PMID:15461867 PMID:18336733 PMID:19251492 PMID:19483382 PMID:25637687 PMID:30452898 More...
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
increases cleavage
ISO
Omeprazole analog results in increased cleavage of CASP8 protein
CTD
PMID:18336733
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cat
catalase
increases activity multiple interactions
ISO EXP
Omeprazole results in increased activity of CAT protein Omeprazole inhibits the reaction [Acetic Acid results in increased activity of CAT protein] Omeprazole inhibits the reaction [Ethanol results in decreased activity of CAT protein]
CTD
PMID:18547560 PMID:28849987 PMID:33245926
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cbr1
carbonyl reductase 1
affects expression
ISO
Omeprazole affects the expression of CBR1 mRNA
CTD
PMID:19483382
NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393
G
Cckbr
cholecystokinin B receptor
multiple interactions
ISO
[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3
CTD
PMID:17704804
NCBI chr 7:105,075,201...105,085,546
Ensembl chr 7:105,074,938...105,120,105
G
Ccnd1
cyclin D1
decreases expression
ISO
Omeprazole results in decreased expression of CCND1 mRNA
CTD
PMID:17202759
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
increases expression
ISO
Omeprazole results in increased expression of CDKN1A protein
CTD
PMID:27358234
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdo1
cysteine dioxygenase 1, cytosolic
affects expression
ISO
Omeprazole affects the expression of CDO1 mRNA
CTD
PMID:19483382
NCBI chr18:46,846,260...46,861,569
Ensembl chr18:46,846,260...46,861,462
G
Cept1
choline/ethanolaminephosphotransferase 1
affects expression
ISO
Omeprazole affects the expression of CEPT1 mRNA
CTD
PMID:19483382
NCBI chr 3:106,409,576...106,455,118
Ensembl chr 3:106,409,576...106,455,118
G
Ces2h
carboxylesterase 2H
affects expression
ISO
Omeprazole affects the expression of CES2 mRNA
CTD
PMID:19483382
NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810
G
Cfi
complement component factor i
affects expression decreases expression
ISO
Omeprazole affects the expression of CFI mRNA Omeprazole results in decreased expression of CFI mRNA
CTD
PMID:19483382 PMID:25626140
NCBI chr 3:129,630,432...129,668,978
Ensembl chr 3:129,629,533...129,668,981
G
Cftr
cystic fibrosis transmembrane conductance regulator
affects metabolic processing
EXP
CFTR protein affects the metabolism of Omeprazole
CTD
PMID:15319328
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Chp1
calcineurin-like EF hand protein 1
affects expression
ISO
Omeprazole affects the expression of CHP1 mRNA
CTD
PMID:19483382
NCBI chr 2:119,378,172...119,417,505
Ensembl chr 2:119,378,178...119,417,508
G
Cisd1
CDGSH iron sulfur domain 1
affects expression
ISO
Omeprazole affects the expression of CISD1 mRNA
CTD
PMID:19483382
NCBI chr10:71,166,324...71,180,679
Ensembl chr10:71,166,310...71,180,784
G
Clcn4
chloride channel, voltage-sensitive 4
affects expression
ISO
Omeprazole affects the expression of CLCN4 mRNA
CTD
PMID:19483382
NCBI chr 7:7,285,308...7,303,837
Ensembl chr 7:7,285,308...7,303,850
G
Clpp
caseinolytic mitochondrial matrix peptidase proteolytic subunit
affects expression
ISO
Omeprazole affects the expression of CLPP mRNA
CTD
PMID:19483382
NCBI chr17:57,297,264...57,303,371
Ensembl chr17:57,297,305...57,303,188
G
Clptm1l
CLPTM1-like
affects expression
ISO
Omeprazole affects the expression of CLPTM1L mRNA
CTD
PMID:19483382
NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724
G
Cmbl
carboxymethylenebutenolidase homolog
affects expression
ISO
Omeprazole affects the expression of CMBL mRNA
CTD
PMID:19483382
NCBI chr15:31,565,314...31,590,266
Ensembl chr15:31,565,535...31,590,265
G
Cmpk1
cytidine/uridine monophosphate kinase 1
affects expression
ISO
Omeprazole affects the expression of CMPK1 mRNA
CTD
PMID:19483382
NCBI chr 4:114,817,810...114,844,425
Ensembl chr 4:114,816,533...114,844,438
G
Copg1
coatomer protein complex, subunit gamma 1
affects expression
ISO
Omeprazole affects the expression of COPG1 mRNA
CTD
PMID:19483382
NCBI chr 6:87,864,801...87,890,577
Ensembl chr 6:87,864,796...87,890,577
G
Cops4
COP9 signalosome subunit 4
affects expression
ISO
Omeprazole affects the expression of COPS4 mRNA
CTD
PMID:19483382
NCBI chr 5:100,666,223...100,695,668
Ensembl chr 5:100,666,175...100,695,669
G
Coq3
coenzyme Q3 methyltransferase
affects expression
ISO
Omeprazole affects the expression of COQ3 mRNA
CTD
PMID:19483382
NCBI chr 4:21,879,646...21,912,163
Ensembl chr 4:21,879,673...21,912,162
G
Cox4i1
cytochrome c oxidase subunit 4I1
affects expression
ISO
Omeprazole affects the expression of COX4I1 mRNA
CTD
PMID:19483382
NCBI chr 8:121,394,964...121,400,948
Ensembl chr 8:121,394,961...121,400,946
G
Cpn1
carboxypeptidase N, polypeptide 1
affects expression
ISO
Omeprazole affects the expression of CPN1 mRNA
CTD
PMID:19483382
NCBI chr19:43,944,746...43,974,990
Ensembl chr19:43,944,746...43,974,995
G
Cpq
carboxypeptidase Q
affects expression
ISO
Omeprazole affects the expression of CPQ mRNA
CTD
PMID:19483382
NCBI chr15:33,083,275...33,594,698
Ensembl chr15:33,083,275...33,594,698
G
Crem
cAMP responsive element modulator
affects expression
ISO
Omeprazole affects the expression of CREM mRNA
CTD
PMID:19483382
NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
G
Csnk2b
casein kinase 2, beta polypeptide
affects expression
ISO
Omeprazole affects the expression of CSNK2B mRNA
CTD
PMID:19483382
NCBI chr17:35,335,171...35,341,029
Ensembl chr17:35,335,172...35,341,029
G
Csrp1
cysteine and glycine-rich protein 1
affects expression
ISO
Omeprazole affects the expression of CSRP1 mRNA
CTD
PMID:19483382
NCBI chr 1:135,614,650...135,679,970
Ensembl chr 1:135,647,799...135,679,970
G
Ctnna1
catenin alpha 1
affects expression
ISO
Omeprazole affects the expression of CTNNA1 mRNA
CTD
PMID:19483382
NCBI chr18:35,251,955...35,387,829
Ensembl chr18:35,251,912...35,387,832
G
Ctsb
cathepsin B
decreases activity
ISO
Omeprazole results in decreased activity of CTSB protein
CTD
PMID:34871754
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Ctsd
cathepsin D
multiple interactions
ISO
Omeprazole inhibits the reaction [Cysteamine results in increased expression of CTSD protein]
CTD
PMID:20165931
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
G
Ctse
cathepsin E
decreases expression
ISO
Omeprazole results in decreased expression of CTSE
CTD
PMID:7575556
NCBI chr 1:131,566,052...131,603,245
Ensembl chr 1:131,566,044...131,603,243
G
Cxcr4
C-X-C motif chemokine receptor 4
decreases expression multiple interactions
ISO
Omeprazole results in decreased expression of CXCR4 mRNA AHR protein affects the reaction [Omeprazole results in decreased expression of CXCR4 mRNA]
CTD
PMID:25826687
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases activity multiple interactions increases expression decreases activity
ISO EXP
Omeprazole results in increased activity of CYP1A1 promoter Omeprazole results in increased activity of CYP1A1 protein AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein mutant form inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Omeprazole results in decreased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; Omeprazole promotes the reaction [AHR protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1A1 promoter] Omeprazole results in increased expression of CYP1A1 mRNA; Omeprazole results in increased expression of CYP1A1 protein [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; AHR protein promotes the reaction [Omeprazole results in increased expression of CYP1A1 protein]; daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Genistein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; Genistein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; herbimycin inhibits the reaction [Omeprazole results in increased activity of CYP1A1 protein]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; lavendustin A inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Staurosporine inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]; Tosyllysine Chloromethyl Ketone inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA] Omeprazole results in decreased activity of CYP1A1 protein Omeprazole inhibits the reaction [Oxygen results in increased expression of CYP1A1 protein]; Omeprazole promotes the reaction [Oxygen results in decreased expression of CYP1A1 mRNA]
CTD
PMID:8647108 PMID:8900397 PMID:9041675 PMID:9139728 PMID:9152597 PMID:9395520 PMID:9860486 PMID:10103034 PMID:10859152 PMID:11454723 PMID:11849738 PMID:12040753 PMID:12623754 PMID:12841937 PMID:14742684 PMID:14987951 PMID:15681896 PMID:15860653 PMID:17202759 PMID:17954527 PMID:18420780 PMID:18502397 PMID:19118567 PMID:20171196 PMID:21666223 PMID:21703235 PMID:21784029 PMID:22687989 PMID:25626140 PMID:25826687 PMID:26187180 PMID:26272953 More...
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases activity decreases activity multiple interactions increases expression
ISO EXP
Omeprazole results in increased activity of CYP1A2 promoter; Omeprazole results in increased activity of CYP1A2 protein Omeprazole results in decreased activity of CYP1A2 protein [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin; AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA]; Omeprazole results in increased expression of and results in increased activity of CYP1A2 protein Omeprazole results in increased expression of CYP1A2 mRNA; Omeprazole results in increased expression of CYP1A2 protein [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA
CTD
PMID:9152597 PMID:9744552 PMID:12040753 PMID:12623754 PMID:12841937 PMID:15681896 PMID:15802389 PMID:16035375 PMID:17954527 PMID:18332078 PMID:18420780 PMID:18502397 PMID:19118567 PMID:19230594 PMID:20171196 PMID:21784029 PMID:21924250 PMID:22524704 PMID:22687989 PMID:23274770 PMID:23850985 PMID:24752503 PMID:25626140 PMID:26204831 PMID:27794450 PMID:30044681 PMID:31863871 PMID:36288780 More...
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions increases expression decreases activity affects expression
ISO EXP
Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [ARNT protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1B1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1B1 promoter] Omeprazole results in increased expression of CYP1B1 mRNA Omeprazole results in decreased activity of CYP1B1 protein Omeprazole affects the expression of CYP1B1 mRNA
CTD
PMID:12040753 PMID:12623754 PMID:18420780 PMID:21703235 PMID:25826687
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Cyp2a22
cytochrome P450, family 2, subfamily a, polypeptide 22
affects expression
ISO
Omeprazole affects the expression of CYP2A1 mRNA
CTD
PMID:19483382
NCBI chr 7:26,631,564...26,638,838
Ensembl chr 7:26,631,056...26,638,809
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
decreases activity increases activity increases expression affects expression
EXP ISO
Omeprazole results in decreased activity of CYP2B10 protein Omeprazole results in increased activity of CYP2B6 protein Omeprazole results in increased expression of CYP2B6 mRNA Omeprazole affects the expression of CYP2B3 mRNA
CTD
PMID:17954527 PMID:18420780 PMID:19118567 PMID:19483382 PMID:22524704
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2b13
cytochrome P450, family 2, subfamily b, polypeptide 13
increases expression affects expression
ISO
Omeprazole results in increased expression of CYP2B2 protein Omeprazole affects the expression of CYP2B2 mRNA
CTD
PMID:9152597 PMID:19483382
NCBI chr 7:25,760,813...25,795,622
Ensembl chr 7:25,760,922...25,795,622
G
Cyp2c37
cytochrome P450, family 2. subfamily c, polypeptide 37
multiple interactions increases metabolic processing
EXP
[CYP2C37 protein results in increased metabolism of Omeprazole] which results in increased chemical synthesis of 5-hydroxymethylomeprazole
CTD
PMID:30503582
NCBI chr19:39,980,868...40,000,687
Ensembl chr19:39,980,868...40,000,687
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
affects metabolic processing decreases metabolic processing increases hydroxylation increases metabolic processing decreases activity multiple interactions
ISO
CYP2C19 protein affects the metabolism of Omeprazole CYP2C19 gene alternative form results in decreased metabolism of Omeprazole CYP2C19 protein results in increased hydroxylation of Omeprazole CYP2C19 protein results in increased metabolism of Omeprazole Omeprazole results in decreased activity of CYP2C19 protein [5-bromotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-chlorotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-fluoro-alpha-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-fluorotryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [5-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [7-methyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Chloramphenicol results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Fluconazole results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [indopan results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [N,N-diisopropyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; [Omeprazole results in decreased activity of CYP2C19 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine metabolite; [Omeprazole results in decreased activity of CYP2C19 protein] which results in decreased chemical synthesis of Aconitine metabolite; [Tryptamines analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole; Omeprazole affects the reaction [CYP2C19 protein affects the metabolism of Warfarin]; Omeprazole inhibits the reaction [CYP2C19 protein results in decreased methylation of adinazolam]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased chemical synthesis of 4-hydroxymephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased hydroxylation of Mephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of auriculasin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of Fluoxetine]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased metabolism of Mephenytoin]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased oxidation of 2-oxo-clopidogrel]; Omeprazole inhibits the reaction [CYP2C19 protein results in increased oxidation of Clopidogrel]
CTD
PMID:8930576 PMID:9600717 PMID:11752104 PMID:12464242 PMID:12467917 PMID:12485723 PMID:12637241 PMID:14586384 PMID:15258107 PMID:15286053 PMID:15306208 PMID:15626586 PMID:16035375 PMID:17565714 PMID:17702393 PMID:18511451 PMID:18520598 PMID:19812348 PMID:20573087 PMID:21277363 PMID:21795468 PMID:21915887 PMID:22634058 PMID:26599973 PMID:31515991 More...
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
multiple interactions decreases activity
ISO EXP
Omeprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] Omeprazole results in decreased activity of CYP2C9 protein
CTD
PMID:15258107 PMID:18420780
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
affects expression decreases activity
ISO EXP
Omeprazole affects the expression of CYP2D4 mRNA Omeprazole results in decreased activity of CYP2D6 protein
CTD
PMID:18420780 PMID:19483382
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO EXP
Omeprazole results in increased expression of and results in increased activity of CYP2E1 protein
CTD
PMID:15802389 PMID:36243147
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp2f2
cytochrome P450, family 2, subfamily f, polypeptide 2
affects expression
ISO
Omeprazole affects the expression of CYP2F4 mRNA
CTD
PMID:19483382
NCBI chr 7:26,819,380...26,833,085
Ensembl chr 7:26,819,334...26,833,085
G
Cyp2j9
cytochrome P450, family 2, subfamily j, polypeptide 9
affects expression
ISO
Omeprazole affects the expression of CYP2J4 mRNA
CTD
PMID:19483382
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
decreases activity
EXP
Omeprazole results in decreased activity of CYP3A11 protein
CTD
PMID:18420780
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
affects expression increases expression
ISO
Omeprazole affects the expression of CYP3A9 mRNA Omeprazole results in increased expression of CYP3A5 mRNA
CTD
PMID:19118567 PMID:19483382
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Cyp3a44
cytochrome P450, family 3, subfamily a, polypeptide 44
decreases activity
EXP
Omeprazole results in decreased activity of CYP3A4 protein
CTD
PMID:18420780
NCBI chr 5:145,710,793...145,742,701
Ensembl chr 5:145,710,793...145,742,684
G
Cyp4f16
cytochrome P450, family 4, subfamily f, polypeptide 16
affects expression
ISO
Omeprazole affects the expression of CYP4F6 mRNA
CTD
PMID:19483382
NCBI chr17:32,755,517...32,770,772
Ensembl chr17:32,755,532...32,770,772
G
Dbi
diazepam binding inhibitor
affects expression
ISO
Omeprazole affects the expression of DBI mRNA
CTD
PMID:19483382
NCBI chr 1:120,041,010...120,048,826
Ensembl chr 1:120,041,010...120,048,808
G
Dcaf11
DDB1 and CUL4 associated factor 11
affects expression
ISO
Omeprazole affects the expression of DCAF11 mRNA
CTD
PMID:19483382
NCBI chr14:55,796,557...55,807,522
Ensembl chr14:55,797,463...55,807,522
G
Dcxr
dicarbonyl L-xylulose reductase
affects expression
ISO
Omeprazole affects the expression of DCXR mRNA
CTD
PMID:19483382
NCBI chr11:120,615,372...120,618,110
Ensembl chr11:120,616,225...120,618,107
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Omeprazole results in increased expression of DDIT3 protein
CTD
PMID:27358234
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Decr1
2,4-dienoyl CoA reductase 1, mitochondrial
affects expression
ISO
Omeprazole affects the expression of DECR1 mRNA
CTD
PMID:19483382
NCBI chr 4:15,917,240...15,945,377
Ensembl chr 4:15,917,240...15,945,507
G
Dexi
dexamethasone-induced transcript
affects expression
ISO
Omeprazole affects the expression of DEXI mRNA
CTD
PMID:19483382
NCBI chr16:10,348,071...10,360,918
Ensembl chr16:10,320,395...10,360,918
G
Dgat1
diacylglycerol O-acyltransferase 1
affects expression
ISO
Omeprazole affects the expression of DGAT1 mRNA
CTD
PMID:19483382
NCBI chr15:76,386,215...76,396,167
Ensembl chr15:76,386,215...76,396,153
G
Dhcr24
24-dehydrocholesterol reductase
affects expression
ISO
Omeprazole affects the expression of DHCR24 mRNA
CTD
PMID:19483382
NCBI chr 4:106,418,279...106,446,310
Ensembl chr 4:106,418,235...106,446,310
G
Dhrs4
dehydrogenase/reductase 4
affects expression
ISO
Omeprazole affects the expression of DHRS4 mRNA
CTD
PMID:19483382
NCBI chr14:55,715,880...55,727,797
Ensembl chr14:55,716,215...55,727,797
G
Dhrs7b
dehydrogenase/reductase 7B
affects expression
ISO
Omeprazole affects the expression of DHRS7B mRNA
CTD
PMID:19483382
NCBI chr11:60,721,457...60,749,249
Ensembl chr11:60,721,457...60,751,021
G
Dhx16
DEAH-box helicase 16
affects expression
ISO
Omeprazole affects the expression of DHX16 mRNA
CTD
PMID:19483382
NCBI chr17:36,190,657...36,203,562
Ensembl chr17:36,190,711...36,203,562
G
Dmac2l
distal membrane arm assembly component 2 like
affects expression
ISO
Omeprazole affects the expression of DMAC2L mRNA
CTD
PMID:19483382
NCBI chr12:69,771,687...69,791,439
Ensembl chr12:69,771,724...69,791,434
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
affects expression
ISO
Omeprazole affects the expression of DNAJC3 mRNA
CTD
PMID:19483382
NCBI chr14:119,175,371...119,219,114
Ensembl chr14:119,175,388...119,219,109
G
Dpp4
dipeptidylpeptidase 4
affects expression
ISO
Omeprazole affects the expression of DPP4 mRNA
CTD
PMID:19483382
NCBI chr 2:62,160,417...62,242,635
Ensembl chr 2:62,160,417...62,242,575
G
Dpyd
dihydropyrimidine dehydrogenase
affects expression
ISO
Omeprazole affects the expression of DPYD mRNA
CTD
PMID:19483382
NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
G
Ears2
glutamyl-tRNA synthetase 2, mitochondrial
affects expression
ISO
Omeprazole affects the expression of EARS2 mRNA
CTD
PMID:19483382
NCBI chr 7:121,633,385...121,666,436
Ensembl chr 7:121,636,436...121,666,486
G
Echs1
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
affects expression
ISO
Omeprazole affects the expression of ECHS1 mRNA
CTD
PMID:19483382
NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
G
Eci1
enoyl-Coenzyme A delta isomerase 1
affects expression
ISO
Omeprazole affects the expression of ECI1 mRNA
CTD
PMID:19483382
NCBI chr17:24,645,657...24,658,290
Ensembl chr17:24,645,615...24,658,322
G
Eci2
enoyl-Coenzyme A delta isomerase 2
affects expression
ISO
Omeprazole affects the expression of ECI2 mRNA
CTD
PMID:19483382
NCBI chr13:35,161,731...35,211,098
Ensembl chr13:35,161,731...35,211,079
G
Eef1g
eukaryotic translation elongation factor 1 gamma
affects expression
ISO
Omeprazole affects the expression of EEF1G mRNA
CTD
PMID:19483382
NCBI chr19:8,944,405...8,955,544
Ensembl chr19:8,944,405...8,955,843
G
Egf
epidermal growth factor
multiple interactions
EXP
Omeprazole promotes the reaction [Indomethacin results in increased expression of EGF protein]
CTD
PMID:18431645
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Ehhadh
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase
affects expression
ISO
Omeprazole affects the expression of EHHADH mRNA
CTD
PMID:19483382
NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557
G
Eif4a2
eukaryotic translation initiation factor 4A2
affects expression
ISO
Omeprazole affects the expression of EIF4A2 mRNA
CTD
PMID:19483382
NCBI chr16:22,924,846...22,932,882
Ensembl chr16:22,926,194...22,932,886
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
affects expression
ISO
Omeprazole affects the expression of EIF4EBP1 mRNA
CTD
PMID:19483382
NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
G
Eif4h
eukaryotic translation initiation factor 4H
affects expression
ISO
Omeprazole affects the expression of EIF4H mRNA
CTD
PMID:19483382
NCBI chr 5:134,648,726...134,668,263
Ensembl chr 5:134,648,575...134,668,344
G
Enc1
ectodermal-neural cortex 1
affects expression
ISO
Omeprazole affects the expression of ENC1 mRNA
CTD
PMID:19483382
NCBI chr13:97,377,613...97,389,548
Ensembl chr13:97,377,613...97,389,542
G
Eno1
enolase 1, alpha non-neuron
affects expression
ISO
Omeprazole affects the expression of ENO1 mRNA
CTD
PMID:19483382
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336 Ensembl chr18:150,321,178...150,333,336
G
Enpep
glutamyl aminopeptidase
affects expression
ISO
Omeprazole affects the expression of ENPEP mRNA
CTD
PMID:19483382
NCBI chr 3:129,062,826...129,126,398
Ensembl chr 3:129,062,824...129,126,369
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
affects expression
ISO
Omeprazole affects the expression of ENPP1 mRNA
CTD
PMID:19483382
NCBI chr10:24,513,812...24,588,057
Ensembl chr10:24,513,812...24,588,057
G
Ep300
E1A binding protein p300
multiple interactions
ISO
Omeprazole promotes the reaction [EP300 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [EP300 protein binds to CYP1B1 promoter]
CTD
PMID:21703235
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Epcam
epithelial cell adhesion molecule
affects expression
ISO
Omeprazole affects the expression of EPCAM mRNA
CTD
PMID:19483382
NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557
G
Erp29
endoplasmic reticulum protein 29
affects expression
ISO
Omeprazole affects the expression of ERP29 mRNA
CTD
PMID:19483382
NCBI chr 5:121,582,816...121,590,537
Ensembl chr 5:121,566,653...121,590,569
G
Esd
esterase D/formylglutathione hydrolase
affects expression
ISO
Omeprazole affects the expression of ESD mRNA
CTD
PMID:19483382
NCBI chr14:74,969,591...74,988,205
Ensembl chr14:74,969,737...74,988,205
G
Etfb
electron transferring flavoprotein, beta polypeptide
affects expression
ISO
Omeprazole affects the expression of ETFB mRNA
CTD
PMID:19483382
NCBI chr 7:43,093,496...43,107,224
Ensembl chr 7:43,093,507...43,107,224
G
Faah
fatty acid amide hydrolase
affects expression
ISO
Omeprazole affects the expression of FAAH mRNA
CTD
PMID:19483382
NCBI chr 4:115,853,866...115,876,034
Ensembl chr 4:115,824,342...115,875,123
G
Fads2
fatty acid desaturase 2
affects expression
ISO
Omeprazole affects the expression of FADS2 mRNA
CTD
PMID:19483382
NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
G
Fbp1
fructose bisphosphatase 1
affects expression
ISO
Omeprazole affects the expression of FBP1 mRNA
CTD
PMID:19483382
NCBI chr13:63,012,567...63,036,112
Ensembl chr13:63,012,567...63,036,096
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
affects expression
ISO
Omeprazole affects the expression of FDFT1 mRNA
CTD
PMID:19483382
NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027
G
Fdps
farnesyl diphosphate synthetase
affects expression
ISO
Omeprazole affects the expression of FDPS mRNA
CTD
PMID:19483382
NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266
G
Fdx2
ferredoxin 2
affects expression
ISO
Omeprazole affects the expression of FDX2 mRNA
CTD
PMID:19483382
NCBI chr 9:20,978,808...20,984,827
Ensembl chr 9:20,978,816...20,984,910
G
Fmo1
flavin containing monooxygenase 1
affects expression
ISO
Omeprazole affects the expression of FMO1 mRNA
CTD
PMID:19483382
NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
G
Gamt
guanidinoacetate methyltransferase
affects expression
ISO
Omeprazole affects the expression of GAMT mRNA
CTD
PMID:19483382
NCBI chr10:80,093,985...80,096,846
Ensembl chr10:80,093,985...80,096,846
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
affects expression
ISO
Omeprazole affects the expression of GAPDH mRNA
CTD
PMID:19483382
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
G
Gast
gastrin
increases expression
EXP ISO
Omeprazole results in increased expression of GAST protein
CTD
PMID:11422300 PMID:12189558 PMID:12763636 PMID:15223672 PMID:16618411 PMID:17652263 More...
NCBI chr11:100,225,233...100,227,823
Ensembl chr11:100,225,233...100,227,822
G
Gbe1
1,4-alpha-glucan branching enzyme 1
affects expression
ISO
Omeprazole affects the expression of GBE1 mRNA
CTD
PMID:19483382
NCBI chr16:70,110,837...70,366,608
Ensembl chr16:70,110,837...70,366,604
G
Gchfr
GTP cyclohydrolase I feedback regulator
affects expression
ISO
Omeprazole affects the expression of GCHFR mRNA
CTD
PMID:19483382
NCBI chr 2:118,998,269...119,002,870
Ensembl chr 2:118,998,254...119,002,871
G
Ggh
gamma-glutamyl hydrolase
affects expression
ISO
Omeprazole affects the expression of GGH mRNA
CTD
PMID:19483382
NCBI chr 4:20,041,963...20,066,111
Ensembl chr 4:20,042,052...20,066,750
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GGT1 mRNA
CTD
PMID:22687989
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Gjb1
gap junction protein, beta 1
affects expression
ISO
Omeprazole affects the expression of GJB1 mRNA
CTD
PMID:19483382
NCBI chr X:100,419,982...100,429,235
Ensembl chr X:100,419,984...100,429,235
G
Gpld1
glycosylphosphatidylinositol specific phospholipase D1
affects expression
ISO
Omeprazole affects the expression of GPLD1 mRNA
CTD
PMID:19483382
NCBI chr13:25,127,135...25,175,919
Ensembl chr13:25,127,135...25,176,484
G
Gpx1
glutathione peroxidase 1
affects expression
ISO
Omeprazole affects the expression of GPX1 mRNA
CTD
PMID:19483382
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx2
glutathione peroxidase 2
multiple interactions
ISO
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA
CTD
PMID:22687989
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
G
Gpx4
glutathione peroxidase 4
affects expression
ISO
Omeprazole affects the expression of GPX4 mRNA
CTD
PMID:19483382
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
G
Grina
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)
affects expression
ISO
Omeprazole affects the expression of GRINA mRNA
CTD
PMID:19483382
NCBI chr15:76,130,917...76,134,109
Ensembl chr15:76,130,964...76,134,104
G
Grpel1
GrpE-like 1, mitochondrial
affects expression
ISO
Omeprazole affects the expression of GRPEL1 mRNA
CTD
PMID:19483382
NCBI chr 5:36,622,529...36,631,421
Ensembl chr 5:36,622,342...36,631,424
G
Gsta1
glutathione S-transferase, alpha 1 (Ya)
multiple interactions increases expression
ISO
[Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA Omeprazole results in increased expression of GSTA5 mRNA
CTD
PMID:17202759 PMID:22687989
NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966
G
Gstp1
glutathione S-transferase, pi 1
increases expression
ISO
Omeprazole results in increased expression of GSTP1 mRNA
CTD
PMID:19118567
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gstt1
glutathione S-transferase, theta 1
affects expression
ISO
Omeprazole affects the expression of GSTT1 mRNA
CTD
PMID:19483382
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Gtf2h5
general transcription factor IIH, polypeptide 5
affects expression
ISO
Omeprazole affects the expression of GTF2H5 mRNA
CTD
PMID:19483382
NCBI chr17:6,130,103...6,135,763
Ensembl chr17:6,130,061...6,136,792
G
Gzma
granzyme A
affects expression
ISO
Omeprazole affects the expression of GZMA mRNA
CTD
PMID:19483382
NCBI chr13:113,230,358...113,237,515
Ensembl chr13:113,230,359...113,237,515
G
H2-DMa
histocompatibility 2, class II, locus DMa
affects expression
ISO
Omeprazole affects the expression of HLA-DMA mRNA
CTD
PMID:25811541
NCBI chr17:34,338,667...34,358,075
Ensembl chr17:34,338,515...34,358,075
G
H2-M2
histocompatibility 2, M region locus 2
affects expression
ISO
Omeprazole affects the expression of HLA-B mRNA
CTD
PMID:25811541
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-M3
histocompatibility 2, M region locus 3
affects expression
ISO
Omeprazole affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
G
H3f3b
H3.3 histone B
affects expression
ISO
Omeprazole affects the expression of H3F3B mRNA
CTD
PMID:19483382
NCBI chr11:115,912,787...115,921,313
Ensembl chr11:115,912,738...115,918,788
G
Hal
histidine ammonia lyase
affects expression
ISO
Omeprazole affects the expression of HAL mRNA
CTD
PMID:19483382
NCBI chr10:93,324,630...93,352,623
Ensembl chr10:93,324,630...93,355,166
G
Hamp
hepcidin antimicrobial peptide
increases expression increases secretion multiple interactions
EXP ISO
Omeprazole results in increased expression of HAMP mRNA; Omeprazole results in increased expression of HAMP protein Omeprazole results in increased secretion of HAMP protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Omeprazole results in increased expression of HAMP mRNA]; AHR protein affects the reaction [Omeprazole results in increased expression of HAMP mRNA]
CTD
PMID:31669099
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hao2
hydroxyacid oxidase 2
affects expression
ISO
Omeprazole affects the expression of HAO2 mRNA
CTD
PMID:19483382
NCBI chr 3:98,781,835...98,802,692
Ensembl chr 3:98,781,837...98,800,555
G
Hba-a2
hemoglobin alpha, adult chain 2
affects expression
ISO
Omeprazole affects the expression of HBA-A2 mRNA
CTD
PMID:19483382
NCBI chr11:32,246,492...32,247,310
Ensembl chr11:32,246,489...32,247,298
G
Hbb-b1
hemoglobin, beta adult major chain
affects expression
ISO
Omeprazole affects the expression of HBB mRNA
CTD
PMID:19483382
G
Hdc
histidine decarboxylase
affects expression multiple interactions increases expression increases stability
ISO
Omeprazole affects the expression of HDC mRNA Omeprazole results in increased expression of and results in increased activity of HDC protein Omeprazole results in increased expression of HDC mRNA Omeprazole results in increased stability of HDC protein
CTD
PMID:12763636 PMID:19483382
NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219
G
Hgd
homogentisate 1, 2-dioxygenase
affects expression
ISO
Omeprazole affects the expression of HGD mRNA
CTD
PMID:19483382
NCBI chr16:37,400,104...37,452,388
Ensembl chr16:37,400,515...37,452,382
G
Hmgn1
high mobility group nucleosomal binding domain 1
affects expression
ISO
Omeprazole affects the expression of HMGN1 mRNA
CTD
PMID:19483382
NCBI chr16:95,922,788...95,928,925
Ensembl chr16:95,921,818...95,928,929
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein]; Omeprazole results in increased expression of and results in increased activity of HMOX1 protein Omeprazole results in increased expression of HMOX1 mRNA; Omeprazole results in increased expression of HMOX1 protein
CTD
PMID:16712795 PMID:27725188
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
affects expression
ISO
Omeprazole affects the expression of HPRT1 mRNA
CTD
PMID:19483382
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
G
Hps5
HPS5, biogenesis of lysosomal organelles complex 2 subunit 2
affects expression
ISO
Omeprazole affects the expression of HPS5 mRNA
CTD
PMID:19483382
NCBI chr 7:46,409,890...46,445,501
Ensembl chr 7:46,409,890...46,445,488
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
affects expression
ISO
Omeprazole affects the expression of HSD17B4 mRNA
CTD
PMID:19483382
NCBI chr18:50,261,268...50,329,337
Ensembl chr18:50,261,268...50,329,336
G
Hsdl2
hydroxysteroid dehydrogenase like 2
affects expression
ISO
Omeprazole affects the expression of HSDL2 mRNA
CTD
PMID:19483382
NCBI chr 4:59,581,515...59,618,694
Ensembl chr 4:59,581,563...59,618,689
G
Hspa1a
heat shock protein 1A
multiple interactions decreases expression
ISO
Zinc Compounds analog inhibits the reaction [Omeprazole results in decreased expression of HSPA1A protein]; Zinc Sulfate inhibits the reaction [Omeprazole results in decreased expression of HSPA1A protein] Omeprazole results in decreased expression of HSPA1A mRNA; Omeprazole results in decreased expression of HSPA1A protein
CTD
PMID:15223672 PMID:16945336
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa1l
heat shock protein 1-like
multiple interactions
ISO
Omeprazole inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA]
CTD
PMID:25637687
NCBI chr17:35,191,679...35,198,204
Ensembl chr17:35,191,679...35,198,261
G
Htra1
HtrA serine peptidase 1
affects expression
ISO
Omeprazole affects the expression of HTRA1 mRNA
CTD
PMID:19483382
NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390
G
Ier3
immediate early response 3
multiple interactions
ISO
[Omeprazole co-treated with CCKBR protein] results in increased expression of IER3
CTD
PMID:17704804
NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815
G
Ifng
interferon gamma
multiple interactions
ISO
Omeprazole inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]
CTD
PMID:19232345
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf1
insulin-like growth factor 1
affects expression
ISO
Omeprazole affects the expression of IGF1 mRNA
CTD
PMID:19483382
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
affects expression
ISO
Omeprazole affects the expression of IGFALS mRNA
CTD
PMID:19483382
NCBI chr17:25,096,818...25,100,985
Ensembl chr17:25,084,971...25,100,984
G
Igfbp2
insulin-like growth factor binding protein 2
affects expression
ISO
Omeprazole affects the expression of IGFBP2 mRNA
CTD
PMID:19483382
NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633
G
Il10
interleukin 10
multiple interactions
EXP
Omeprazole inhibits the reaction [Ethanol results in decreased expression of IL10 protein]
CTD
PMID:26970604
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Omeprazole inhibits the reaction [Cisplatin results in increased expression of IL1B protein]
CTD
PMID:32418911
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
multiple interactions
ISO
Omeprazole inhibits the reaction [Cisplatin results in increased expression of IL6 protein]; Omeprazole inhibits the reaction [Ethanol results in decreased expression of IL6 protein]
CTD
PMID:25637687 PMID:32418911
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Impa1
inositol (myo)-1(or 4)-monophosphatase 1
affects expression
ISO
Omeprazole affects the expression of IMPA1 mRNA
CTD
PMID:19483382
NCBI chr 3:10,377,016...10,396,499
Ensembl chr 3:10,377,016...10,396,499
G
Inhbe
inhibin beta-E
affects expression
ISO
Omeprazole affects the expression of INHBE mRNA
CTD
PMID:19483382
NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
G
Isyna1
myo-inositol 1-phosphate synthase A1
affects expression
ISO
Omeprazole affects the expression of ISYNA1 mRNA
CTD
PMID:19483382
NCBI chr 8:71,047,131...71,049,940
Ensembl chr 8:71,047,023...71,049,940
G
Itih4
inter alpha-trypsin inhibitor, heavy chain 4
affects expression
ISO
Omeprazole affects the expression of ITIH4 mRNA
CTD
PMID:19483382
NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
G
Jak1
Janus kinase 1
affects expression
ISO
Omeprazole affects the expression of JAK1 mRNA
CTD
PMID:19483382
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
G
Kdelr2
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
affects expression
ISO
Omeprazole affects the expression of KDELR2 mRNA
CTD
PMID:19483382
NCBI chr 5:143,389,575...143,407,659
Ensembl chr 5:143,389,593...143,407,656
G
Kdr
kinase insert domain protein receptor
affects expression multiple interactions
ISO EXP
Omeprazole affects the expression of KDR mRNA Omeprazole promotes the reaction [Oxygen results in decreased expression of KDR protein]
CTD
PMID:19483382 PMID:26272953
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Krt8
keratin 8
affects expression
ISO
Omeprazole affects the expression of KRT8 mRNA
CTD
PMID:19483382
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Lcat
lecithin cholesterol acyltransferase
affects expression
ISO
Omeprazole affects the expression of LCAT mRNA
CTD
PMID:19483382
NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014
G
Lcmt1
leucine carboxyl methyltransferase 1
affects expression
ISO
Omeprazole affects the expression of LCMT1 mRNA
CTD
PMID:19483382
NCBI chr 7:122,977,026...123,029,581
Ensembl chr 7:122,969,007...123,029,581
G
Lipc
lipase, hepatic
affects expression
ISO
Omeprazole affects the expression of LIPC mRNA
CTD
PMID:19483382
NCBI chr 9:70,705,410...70,859,503
Ensembl chr 9:70,705,410...70,859,508
G
Lox
lysyl oxidase
affects expression
ISO
Omeprazole affects the expression of LOX mRNA
CTD
PMID:19483382
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Lrp3
low density lipoprotein receptor-related protein 3
affects expression
ISO
Omeprazole affects the expression of LRP3 mRNA
CTD
PMID:19483382
NCBI chr 7:34,900,303...34,914,770
Ensembl chr 7:34,899,452...34,914,923
G
Man2b1
mannosidase 2, alpha B1
affects expression
ISO
Omeprazole affects the expression of MAN2B1 mRNA
CTD
PMID:19483382
NCBI chr 8:85,809,941...85,824,215
Ensembl chr 8:85,809,899...85,824,911
G
Map2k2
mitogen-activated protein kinase kinase 2
affects expression
ISO
Omeprazole affects the expression of MAP2K2 mRNA
CTD
PMID:19483382
NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809
G
Mapk14
mitogen-activated protein kinase 14
multiple interactions
ISO
Omeprazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of MAPK14 protein]
CTD
PMID:17406807
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Masp2
MBL associated serine protease 2
affects expression
ISO
Omeprazole affects the expression of MASP2 mRNA
CTD
PMID:19483382
NCBI chr 4:148,679,079...148,699,939
Ensembl chr 4:148,687,011...148,699,956
G
Me1
malic enzyme 1, NADP(+)-dependent, cytosolic
affects expression multiple interactions
ISO
Omeprazole affects the expression of ME1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA
CTD
PMID:19483382 PMID:22687989
NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
G
Mmp14
matrix metallopeptidase 14 (membrane-inserted)
multiple interactions
ISO
Omeprazole inhibits the reaction [Indomethacin results in decreased expression of MMP14 protein]
CTD
PMID:16934674
NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
Omeprazole inhibits the reaction [Hydrogen Peroxide results in decreased activity of MMP2 protein]
CTD
PMID:16934674
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmut
methylmalonyl-Coenzyme A mutase
affects expression
ISO
Omeprazole affects the expression of MMUT mRNA
CTD
PMID:19483382
NCBI chr17:41,245,576...41,272,880
Ensembl chr17:41,245,576...41,272,879
G
Mpo
myeloperoxidase
multiple interactions decreases activity
EXP ISO
Omeprazole inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Acids results in increased activity of MPO protein] Omeprazole inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Cysteamine results in increased expression of MPO protein]; Omeprazole inhibits the reaction [Ethanol results in increased activity of MPO protein]; Omeprazole inhibits the reaction [Indomethacin results in increased activity of MPO protein] Omeprazole results in decreased activity of MPO protein
CTD
PMID:16091555 PMID:17151854 PMID:20165931 PMID:25637687 PMID:27780710 PMID:29770154 PMID:31095933 PMID:33245926 More...
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mro
maestro
affects expression
ISO
Omeprazole affects the expression of MRO mRNA
CTD
PMID:19483382
NCBI chr18:73,992,465...74,014,405
Ensembl chr18:73,992,456...74,014,404
G
Mrpl2
mitochondrial ribosomal protein L2
affects expression
ISO
Omeprazole affects the expression of MRPL2 mRNA
CTD
PMID:19483382
NCBI chr17:46,957,094...46,961,058
Ensembl chr17:46,957,155...46,961,065
G
Mrpl9
mitochondrial ribosomal protein L9
affects expression
ISO
Omeprazole affects the expression of MRPL9 mRNA
CTD
PMID:19483382
NCBI chr 3:94,350,631...94,355,831
Ensembl chr 3:94,350,625...94,358,437
G
Mug2
murinoglobulin 2
affects expression
ISO
Omeprazole affects the expression of PZP mRNA
CTD
PMID:19483382
NCBI chr 6:121,983,688...122,062,927
Ensembl chr 6:121,983,720...122,062,924
G
Myadm
myeloid-associated differentiation marker
affects expression
ISO
Omeprazole affects the expression of MYADM mRNA
CTD
PMID:19483382
NCBI chr 7:3,337,563...3,347,871
Ensembl chr 7:3,337,605...3,348,958
G
Mycbp2
MYC binding protein 2, E3 ubiquitin protein ligase
affects expression
ISO
Omeprazole affects the expression of MYCBP2 mRNA
CTD
PMID:19483382
NCBI chr14:103,350,847...103,584,276
Ensembl chr14:103,350,847...103,584,250
G
Myo1d
myosin ID
affects expression
ISO
Omeprazole affects the expression of MYO1D mRNA
CTD
PMID:19483382
NCBI chr11:80,372,945...80,670,881
Ensembl chr11:80,372,952...80,670,851
G
Naa38
N(alpha)-acetyltransferase 38, NatC auxiliary subunit
affects expression
ISO
Omeprazole affects the expression of NAA38 mRNA
CTD
PMID:19483382
NCBI chr11:69,286,617...69,287,497
Ensembl chr11:69,286,313...69,287,506
G
Nap1l1
nucleosome assembly protein 1-like 1
affects expression
ISO
Omeprazole affects the expression of NAP1L1 mRNA
CTD
PMID:19483382
NCBI chr10:111,308,754...111,334,011
Ensembl chr10:111,309,084...111,334,011
G
Nat8
N-acetyltransferase 8 (GCN5-related)
affects expression
ISO
Omeprazole affects the expression of NAT8 mRNA
CTD
PMID:19483382
NCBI chr 6:85,807,369...85,813,839
Ensembl chr 6:85,807,370...85,809,064
G
Ncoa1
nuclear receptor coactivator 1
multiple interactions
ISO
Omeprazole promotes the reaction [NCOA1 protein binds to CYP1A1 promoter]; Omeprazole promotes the reaction [NCOA1 protein binds to CYP1B1 promoter]
CTD
PMID:21703235
NCBI chr12:4,297,362...4,569,452
Ensembl chr12:4,297,362...4,527,182
G
Ndrg2
N-myc downstream regulated gene 2
affects expression
ISO
Omeprazole affects the expression of NDRG2 mRNA
CTD
PMID:19483382
NCBI chr14:52,142,738...52,151,463
Ensembl chr14:52,142,728...52,151,615
G
Ndufs5
NADH:ubiquinone oxidoreductase core subunit S5
affects expression
ISO
Omeprazole affects the expression of NDUFS5 mRNA
CTD
PMID:19483382
NCBI chr 4:123,606,503...123,611,979
Ensembl chr 4:123,606,503...123,611,995
G
Ndufv3
NADH:ubiquinone oxidoreductase core subunit V3
affects expression
ISO
Omeprazole affects the expression of NDUFV3 mRNA
CTD
PMID:19483382
NCBI chr17:31,739,089...31,750,300
Ensembl chr17:31,739,089...31,750,305
G
Neu2
neuraminidase 2
affects expression
ISO
Omeprazole affects the expression of NEU2 mRNA
CTD
PMID:19483382
NCBI chr 1:87,501,749...87,525,567
Ensembl chr 1:87,437,611...87,525,567
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions
ISO
NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein]
CTD
PMID:27725188
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
multiple interactions
ISO
Omeprazole inhibits the reaction [Cisplatin results in decreased expression of NFKBIA protein]
CTD
PMID:32418911
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nfx1
nuclear transcription factor, X-box binding 1
affects expression
ISO
Omeprazole affects the expression of NFX1 mRNA
CTD
PMID:19483382
NCBI chr 4:40,970,906...41,025,992
Ensembl chr 4:40,970,906...41,025,993
G
Nipal2
NIPA-like domain containing 2
affects expression
ISO
Omeprazole affects the expression of NIPAL2 mRNA
CTD
PMID:19483382
NCBI chr15:34,572,942...34,679,739
Ensembl chr15:34,572,945...34,679,358
G
Nit1
nitrilase 1
affects expression
ISO
Omeprazole affects the expression of NIT1 mRNA
CTD
PMID:19483382
NCBI chr 1:171,168,145...171,173,209
Ensembl chr 1:171,165,576...171,173,214
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
Lipopolysaccharides inhibits the reaction [Omeprazole inhibits the reaction [Cisplatin results in increased expression of NLRP3 protein]]; Omeprazole inhibits the reaction [Cisplatin results in increased expression of NLRP3 protein]
CTD
PMID:32418911
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
affects expression
ISO
Omeprazole affects the expression of NME2 mRNA
CTD
PMID:19483382
NCBI chr11:93,840,640...93,847,082
Ensembl chr11:93,840,640...93,847,085
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
increases expression multiple interactions
ISO EXP
Omeprazole results in increased expression of NQO1 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 mRNA]; Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 protein]
CTD
PMID:17202759 PMID:22687989 PMID:26272953
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions increases activity
ISO
[Omeprazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; NR1I2 protein affects the reaction [Omeprazole results in increased expression of CYP3A4 mRNA]
CTD
PMID:12695340 PMID:17041008 PMID:25680588 PMID:26187274 PMID:27732639
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
affects expression increases expression decreases metabolic processing
ISO EXP
Omeprazole affects the expression of NR1I3 mRNA Omeprazole results in increased expression of NR1I3 mRNA NR1I3 gene mutant form results in decreased metabolism of Omeprazole
CTD
PMID:19118567 PMID:19483382 PMID:27434302
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects expression
ISO
Omeprazole affects the expression of NR3C1 mRNA
CTD
PMID:19483382
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Oaf
out at first homolog
affects expression
ISO
Omeprazole affects the expression of OAF mRNA
CTD
PMID:19483382
NCBI chr 9:43,132,575...43,151,113
Ensembl chr 9:43,132,532...43,151,208
G
Ogdh
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
affects expression
ISO
Omeprazole affects the expression of OGDH mRNA
CTD
PMID:19483382
NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642
G
Or51e2
olfactory receptor family 51 subfamily E member 2
affects expression
ISO
Omeprazole affects the expression of OLR59 mRNA
CTD
PMID:19483382
NCBI chr 7:102,389,928...102,408,678
Ensembl chr 7:102,387,718...102,408,678
G
Ostc
oligosaccharyltransferase complex subunit (non-catalytic)
affects expression
ISO
Omeprazole affects the expression of OSTC mRNA
CTD
PMID:19483382
NCBI chr 3:130,489,566...130,503,093
Ensembl chr 3:130,489,561...130,503,093
G
Otc
ornithine transcarbamylase
affects expression
ISO
Omeprazole affects the expression of OTC mRNA
CTD
PMID:19483382
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
G
Pabpc4
poly(A) binding protein, cytoplasmic 4
affects expression
ISO
Omeprazole affects the expression of PABPC4 mRNA
CTD
PMID:19483382
NCBI chr 4:123,172,722...123,192,718
Ensembl chr 4:123,156,144...123,192,718
G
Paics
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase
affects expression
ISO
Omeprazole affects the expression of PAICS mRNA
CTD
PMID:19483382
NCBI chr 5:77,099,149...77,115,356
Ensembl chr 5:77,099,154...77,115,356
G
Parp1
poly (ADP-ribose) polymerase family, member 1
increases cleavage
ISO
Omeprazole results in increased cleavage of PARP1 protein
CTD
PMID:15461867
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pccb
propionyl Coenzyme A carboxylase, beta polypeptide
affects expression
ISO
Omeprazole affects the expression of PCCB mRNA
CTD
PMID:19483382
NCBI chr 9:100,864,085...100,916,993
Ensembl chr 9:100,864,085...100,916,951
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO EXP
[Omeprazole co-treated with Indomethacin] promotes the reaction [Acetic Acid results in increased expression of PCNA protein]; Omeprazole promotes the reaction [Acetic Acid results in increased expression of PCNA protein] Omeprazole inhibits the reaction [Ethanol results in decreased expression of PCNA protein]
CTD
PMID:19251492 PMID:26970604
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pcsk6
proprotein convertase subtilisin/kexin type 6
affects expression
ISO
Omeprazole affects the expression of PCSK6 mRNA
CTD
PMID:19483382
NCBI chr 7:65,511,884...65,700,134
Ensembl chr 7:65,511,482...65,700,134
G
Pctp
phosphatidylcholine transfer protein
affects expression
ISO
Omeprazole affects the expression of PCTP mRNA
CTD
PMID:19483382
NCBI chr11:89,873,370...89,893,720
Ensembl chr11:89,873,491...89,893,720
G
Pcx
pyruvate carboxylase
affects expression
ISO
Omeprazole affects the expression of PCX mRNA
CTD
PMID:19483382
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
G
Pdcl3
phosducin-like 3
affects expression
ISO
Omeprazole affects the expression of PDCL3 mRNA
CTD
PMID:19483382
NCBI chr 1:39,026,895...39,036,317
Ensembl chr 1:39,024,689...39,036,319
G
Pdia3
protein disulfide isomerase associated 3
affects expression
ISO
Omeprazole affects the expression of PDIA3 mRNA
CTD
PMID:19483382
NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168
G
Pdia6
protein disulfide isomerase associated 6
affects expression
ISO
Omeprazole affects the expression of PDIA6 mRNA
CTD
PMID:19483382
NCBI chr12:17,316,590...17,334,786
Ensembl chr12:17,316,546...17,334,771
G
Pex19
peroxisomal biogenesis factor 19
affects expression
ISO
Omeprazole affects the expression of PEX19 mRNA
CTD
PMID:19483382
NCBI chr 1:171,954,322...171,964,064
Ensembl chr 1:171,954,322...171,964,060
G
Pgam1
phosphoglycerate mutase 1
affects expression
ISO
Omeprazole affects the expression of PGAM1 mRNA
CTD
PMID:19483382
NCBI chr19:41,900,310...41,907,104
Ensembl chr19:41,900,362...41,907,099
G
Pgrmc1
progesterone receptor membrane component 1
affects expression
ISO
Omeprazole affects the expression of PGRMC1 mRNA
CTD
PMID:19483382
NCBI chr X:35,861,846...35,869,732
Ensembl chr X:35,861,859...35,869,732
G
Phyh
phytanoyl-CoA hydroxylase
affects expression
ISO
Omeprazole affects the expression of PHYH mRNA
CTD
PMID:19483382
NCBI chr 2:4,923,807...4,943,554
Ensembl chr 2:4,923,830...4,943,541
G
Pigp
phosphatidylinositol glycan anchor biosynthesis, class P
affects expression
ISO
Omeprazole affects the expression of PIGP mRNA
CTD
PMID:19483382
NCBI chr16:94,159,622...94,171,874
Ensembl chr16:94,159,622...94,172,701
G
Pklr
pyruvate kinase liver and red blood cell
affects expression
ISO
Omeprazole affects the expression of PKLR mRNA
CTD
PMID:19483382
NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091
G
Pla2g4a
phospholipase A2, group IVA (cytosolic, calcium-dependent)
increases phosphorylation multiple interactions
ISO
Omeprazole results in increased phosphorylation of PLA2G4A protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Omeprazole results in increased phosphorylation of PLA2G4A protein]
CTD
PMID:25797602
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
G
Plbd1
phospholipase B domain containing 1
affects expression
ISO
Omeprazole affects the expression of PLBD1 mRNA
CTD
PMID:19483382
NCBI chr 6:136,589,069...136,639,301
Ensembl chr 6:136,589,068...136,638,926
G
Plg
plasminogen
affects expression
ISO
Omeprazole affects the expression of PLG mRNA
CTD
PMID:19483382
NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
G
Pls3
plastin 3 (T-isoform)
affects expression
ISO
Omeprazole affects the expression of PLS3 mRNA
CTD
PMID:19483382
NCBI chr X:74,829,259...74,918,788
Ensembl chr X:74,829,260...74,918,788
G
Pon2
paraoxonase 2
affects expression
ISO
Omeprazole affects the expression of PON2 mRNA
CTD
PMID:19483382
NCBI chr 6:5,264,620...5,298,408
Ensembl chr 6:5,264,147...5,298,455
G
Pou2f2
POU domain, class 2, transcription factor 2
multiple interactions
ISO
Omeprazole inhibits the reaction [Cisplatin results in increased expression of POU2F2 protein]
CTD
PMID:30452898
NCBI chr 7:24,790,111...24,879,292
Ensembl chr 7:24,786,769...24,879,151
G
Ppdpf
pancreatic progenitor cell differentiation and proliferation factor
affects expression
ISO
Omeprazole affects the expression of PPDPF mRNA
CTD
PMID:19483382
NCBI chr 2:180,828,615...180,830,297
Ensembl chr 2:180,829,040...180,830,564
G
Prdx2
peroxiredoxin 2
affects expression
ISO
Omeprazole affects the expression of PRDX2 mRNA
CTD
PMID:19483382
NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463
G
Prdx6
peroxiredoxin 6
affects expression
ISO
Omeprazole affects the expression of PRDX6 mRNA
CTD
PMID:19483382
NCBI chr 1:161,067,682...161,078,780
Ensembl chr 1:161,067,682...161,078,789
G
Prl
prolactin
increases expression
ISO
Omeprazole results in increased expression of PRL protein
CTD
PMID:20726208
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Proc
protein C
affects expression
ISO
Omeprazole affects the expression of PROC mRNA
CTD
PMID:19483382
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Prpsap1
phosphoribosyl pyrophosphate synthetase-associated protein 1
affects expression
ISO
Omeprazole affects the expression of PRPSAP1 mRNA
CTD
PMID:19483382
NCBI chr11:116,361,641...116,385,739
Ensembl chr11:116,361,671...116,385,461
G
Psma6
proteasome subunit alpha 6
affects expression
ISO
Omeprazole affects the expression of PSMA6 mRNA
CTD
PMID:19483382
NCBI chr12:55,431,007...55,465,244
Ensembl chr12:55,431,007...55,465,239
G
Psmb1
proteasome (prosome, macropain) subunit, beta type 1
affects expression
ISO
Omeprazole affects the expression of PSMB1 mRNA
CTD
PMID:19483382
NCBI chr17:15,695,983...15,718,538
Ensembl chr17:15,695,283...15,720,013
G
Psmb3
proteasome (prosome, macropain) subunit, beta type 3
affects expression
ISO
Omeprazole affects the expression of PSMB3 mRNA
CTD
PMID:19483382
NCBI chr11:97,594,260...97,604,326
Ensembl chr11:97,594,225...97,604,326
G
Psmc1
protease (prosome, macropain) 26S subunit, ATPase 1
affects expression
ISO
Omeprazole affects the expression of PSMC1 mRNA
CTD
PMID:19483382
NCBI chr12:100,076,461...100,089,623
Ensembl chr12:100,076,413...100,089,664
G
Psmc3
proteasome (prosome, macropain) 26S subunit, ATPase 3
affects expression
ISO
Omeprazole affects the expression of PSMC3 mRNA
CTD
PMID:19483382
NCBI chr 2:90,884,361...90,889,783
Ensembl chr 2:90,884,354...90,896,714
G
Psmc5
protease (prosome, macropain) 26S subunit, ATPase 5
affects expression
ISO
Omeprazole affects the expression of PSMC5 mRNA
CTD
PMID:19483382
NCBI chr11:106,147,011...106,153,938
Ensembl chr11:106,146,980...106,153,946
G
Psmd1
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1
affects expression
ISO
Omeprazole affects the expression of PSMD1 mRNA
CTD
PMID:19483382
NCBI chr 1:85,992,341...86,067,017
Ensembl chr 1:85,992,109...86,066,873
G
Psmd4
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
affects expression
ISO
Omeprazole affects the expression of PSMD4 mRNA
CTD
PMID:19483382
NCBI chr 3:94,939,999...94,949,880
Ensembl chr 3:94,940,005...94,949,925
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO EXP
[Omeprazole co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA; [Omeprazole co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein Omeprazole inhibits the reaction [Ethanol results in increased expression of PTGS2 protein]
CTD
PMID:23038005 PMID:26970604
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptms
parathymosin
affects expression
ISO
Omeprazole affects the expression of PTMS mRNA
CTD
PMID:19483382
NCBI chr 6:124,890,638...124,894,909
Ensembl chr 6:124,890,644...124,897,066
G
Ptprf
protein tyrosine phosphatase receptor type F
affects expression
ISO
Omeprazole affects the expression of PTPRF mRNA
CTD
PMID:19483382
NCBI chr 4:118,065,410...118,148,602
Ensembl chr 4:118,065,410...118,148,602
G
Pttg1ip
pituitary tumor-transforming 1 interacting protein
affects expression
ISO
Omeprazole affects the expression of PTTG1IP mRNA
CTD
PMID:19483382
NCBI chr10:77,417,489...77,434,566
Ensembl chr10:77,417,554...77,434,566
G
Pygl
liver glycogen phosphorylase
affects expression
ISO
Omeprazole affects the expression of PYGL mRNA
CTD
PMID:19483382
NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
G
Rab5if
RAB5 interacting factor
affects expression
ISO
Omeprazole affects the expression of RAB5IF mRNA
CTD
PMID:19483382
NCBI chr 2:156,705,042...156,715,483
Ensembl chr 2:156,705,048...156,715,483
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
[Omeprazole co-treated with Indomethacin] promotes the reaction [Acetic Acid results in increased expression of RELA protein]; Lipopolysaccharides inhibits the reaction [Omeprazole inhibits the reaction [Cisplatin results in increased phosphorylation of RELA protein]]; Omeprazole inhibits the reaction [Cisplatin results in increased phosphorylation of RELA protein] Omeprazole inhibits the reaction [Cisplatin affects the localization of RELA protein]
CTD
PMID:19251492 PMID:30452898 PMID:32418911
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Retsat
retinol saturase (all trans retinol 13,14 reductase)
increases expression
ISO
Omeprazole results in increased expression of RETSAT mRNA
CTD
PMID:25626140
NCBI chr 6:72,575,585...72,584,471
Ensembl chr 6:72,575,458...72,585,408
G
Rida
reactive intermediate imine deaminase A homolog
affects expression
ISO
Omeprazole affects the expression of RIDA mRNA
CTD
PMID:19483382
NCBI chr15:34,484,168...34,495,392
Ensembl chr15:34,484,167...34,495,401
G
Rnase4
ribonuclease, RNase A family 4
affects expression
ISO
Omeprazole affects the expression of RNASE4 mRNA
CTD
PMID:19483382
NCBI chr14:51,328,534...51,343,608
Ensembl chr14:51,328,534...51,343,608
G
Rnf103
ring finger protein 103
affects expression
ISO
Omeprazole affects the expression of RNF103 mRNA
CTD
PMID:19483382
NCBI chr 6:71,470,828...71,487,864
Ensembl chr 6:71,470,878...71,487,865
G
Rnps1
RNA binding protein with serine rich domain 1
affects expression
ISO
Omeprazole affects the expression of RNPS1 mRNA
CTD
PMID:19483382
NCBI chr17:24,633,620...24,644,872
Ensembl chr17:24,633,539...24,644,875
G
Rpl11
ribosomal protein L11
affects expression
ISO
Omeprazole affects the expression of RPL11 mRNA
CTD
PMID:19483382
NCBI chr 4:135,776,665...135,780,704
Ensembl chr 4:135,755,576...135,780,739
G
Rpl13
ribosomal protein L13
affects expression
ISO
Omeprazole affects the expression of RPL13 mRNA
CTD
PMID:19483382
NCBI chr 8:123,829,089...123,831,983
Ensembl chr 8:123,829,089...123,831,983
G
Rpl15
ribosomal protein L15
affects expression
ISO
Omeprazole affects the expression of RPL15 mRNA
CTD
PMID:19483382
NCBI chr14:4,198,710...4,201,873
Ensembl chr14:4,198,305...4,201,873
G
Rpl17
ribosomal protein L17
affects expression
ISO
Omeprazole affects the expression of RPL17 mRNA
CTD
PMID:19483382
NCBI chr18:75,132,049...75,136,455
Ensembl chr18:75,131,629...75,136,452
G
Rpl23
ribosomal protein L23
affects expression
ISO
Omeprazole affects the expression of RPL23 mRNA
CTD
PMID:19483382
NCBI chr11:97,668,352...97,673,265
Ensembl chr11:97,668,353...97,673,263
G
Rpl3
ribosomal protein L3
affects expression
ISO
Omeprazole affects the expression of RPL3 mRNA
CTD
PMID:19483382
NCBI chr15:79,961,993...79,967,553
Ensembl chr15:79,961,992...79,976,069
G
Rpl32
ribosomal protein L32
affects expression
ISO
Omeprazole affects the expression of RPL32 mRNA
CTD
PMID:19483382
NCBI chr 6:115,782,475...115,785,704
Ensembl chr 6:115,782,466...115,785,708
G
Rpl4
ribosomal protein L4
affects expression
ISO
Omeprazole affects the expression of RPL4 mRNA
CTD
PMID:19483382
NCBI chr 9:64,080,159...64,085,805
Ensembl chr 9:64,080,657...64,085,948
G
Rpn2
ribophorin II
affects expression
ISO
Omeprazole affects the expression of RPN2 mRNA
CTD
PMID:19483382
NCBI chr 2:157,121,018...157,168,238
Ensembl chr 2:157,120,937...157,168,239
G
Rps14
ribosomal protein S14
affects expression
ISO
Omeprazole affects the expression of RPS14 mRNA
CTD
PMID:19483382
NCBI chr18:60,907,668...60,911,618
Ensembl chr18:60,880,170...60,911,618
G
Rps18
ribosomal protein S18
affects expression
ISO
Omeprazole affects the expression of RPS18 mRNA
CTD
PMID:19483382
NCBI chr17:34,170,972...34,174,639
Ensembl chr17:34,170,973...34,174,975
G
Rps19
ribosomal protein S19
affects expression
ISO
Omeprazole affects the expression of RPS19 mRNA
CTD
PMID:19483382
NCBI chr 7:24,584,013...24,589,236
Ensembl chr 7:24,583,796...24,589,231
G
Rps20
ribosomal protein S20
affects expression
ISO
Omeprazole affects the expression of RPS20 mRNA
CTD
PMID:19483382
NCBI chr 4:3,831,334...3,835,600
Ensembl chr 4:3,831,334...3,835,665
G
Rps3a1
ribosomal protein S3A1
affects expression
ISO
Omeprazole affects the expression of RPS3A mRNA
CTD
PMID:19483382
NCBI chr 3:86,045,247...86,049,975
Ensembl chr 3:86,045,247...86,050,009
G
Rps6
ribosomal protein S6
affects expression
ISO
Omeprazole affects the expression of RPS6 mRNA
CTD
PMID:19483382
NCBI chr 4:86,772,336...86,775,604
Ensembl chr 4:86,772,897...86,775,649
G
Rps8
ribosomal protein S8
affects expression
ISO
Omeprazole affects the expression of RPS8 mRNA
CTD
PMID:19483382
NCBI chr 4:117,011,033...117,013,329
Ensembl chr 4:117,011,024...117,013,440
G
Rras2
related RAS viral (r-ras) oncogene 2
affects expression
ISO
Omeprazole affects the expression of RRAS2 mRNA
CTD
PMID:19483382
NCBI chr 7:113,646,017...113,717,016
Ensembl chr 7:113,646,017...113,717,016
G
S1pr1
sphingosine-1-phosphate receptor 1
affects expression
ISO
Omeprazole affects the expression of S1PR1 mRNA
CTD
PMID:19483382
NCBI chr 3:115,504,082...115,508,704
Ensembl chr 3:115,504,082...115,508,721
G
Sbspon
somatomedin B and thrombospondin, type 1 domain containing
affects expression
ISO
Omeprazole affects the expression of SBSPON mRNA
CTD
PMID:19483382
NCBI chr 1:15,924,086...15,962,946
Ensembl chr 1:15,924,086...15,962,946
G
Sdc2
syndecan 2
affects expression
ISO
Omeprazole affects the expression of SDC2 mRNA
CTD
PMID:19483382
NCBI chr15:32,920,869...33,034,867
Ensembl chr15:32,920,869...33,035,081
G
Sdhc
succinate dehydrogenase complex, subunit C, integral membrane protein
affects expression
ISO
Omeprazole affects the expression of SDHC mRNA
CTD
PMID:19483382
NCBI chr 1:170,956,726...170,978,209
Ensembl chr 1:170,954,734...170,978,172
G
Sdhd
succinate dehydrogenase complex, subunit D, integral membrane protein
affects expression
ISO
Omeprazole affects the expression of SDHD mRNA
CTD
PMID:19483382
NCBI chr 9:50,507,640...50,515,149
Ensembl chr 9:50,507,657...50,515,112
G
Sell
selectin, lymphocyte
decreases expression
ISO
Omeprazole results in decreased expression of SELL protein
CTD
PMID:17652263
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Serinc3
serine incorporator 3
affects expression
ISO
Omeprazole affects the expression of SERINC3 mRNA
CTD
PMID:19483382
NCBI chr 2:163,466,577...163,487,767
Ensembl chr 2:163,465,192...163,487,051
G
Serpina10
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
affects expression
ISO
Omeprazole affects the expression of SERPINA10 mRNA
CTD
PMID:19483382
NCBI chr12:103,582,934...103,597,681
Ensembl chr12:103,581,045...103,597,703
G
Serpina4-ps1
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1
affects expression
ISO
Omeprazole affects the expression of SERPINA4 mRNA
CTD
PMID:19483382
NCBI chr12:104,044,218...104,053,179
Ensembl chr12:104,046,908...104,052,983
G
Serpinf2
serine (or cysteine) peptidase inhibitor, clade F, member 2
affects expression
ISO
Omeprazole affects the expression of SERPINF2 mRNA
CTD
PMID:19483382
NCBI chr11:75,322,562...75,330,327
Ensembl chr11:75,322,558...75,330,417
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
decreases expression
ISO
Omeprazole results in decreased expression of SERPING1 mRNA
CTD
PMID:25626140
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Sfxn1
sideroflexin 1
affects expression
ISO
Omeprazole affects the expression of SFXN1 mRNA
CTD
PMID:19483382
NCBI chr13:54,225,675...54,262,365
Ensembl chr13:54,225,888...54,262,361
G
Shmt2
serine hydroxymethyltransferase 2 (mitochondrial)
affects expression
ISO
Omeprazole affects the expression of SHMT2 mRNA
CTD
PMID:19483382
NCBI chr10:127,352,992...127,358,313
Ensembl chr10:127,352,992...127,358,313
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
affects expression
ISO
Omeprazole affects the expression of SLC22A1 mRNA
CTD
PMID:19483382
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
multiple interactions
ISO
Omeprazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc22a5
solute carrier family 22 (organic cation transporter), member 5
multiple interactions
ISO
Dithioerythritol inhibits the reaction [Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]]; Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]
CTD
PMID:19041296
NCBI chr11:53,755,368...53,782,609
Ensembl chr11:53,755,368...53,782,486
G
Slc22a8
solute carrier family 22 (organic anion transporter), member 8
multiple interactions
ISO
[Omeprazole results in decreased activity of SLC22A8 protein] which results in decreased uptake of Indican
CTD
PMID:36243147
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
G
Slc23a1
solute carrier family 23 (nucleobase transporters), member 1
affects expression
ISO
Omeprazole affects the expression of SLC23A1 mRNA
CTD
PMID:19483382
NCBI chr18:35,747,657...35,762,900
Ensembl chr18:35,747,657...35,760,297
G
Slc25a13
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13
affects expression
ISO
Omeprazole affects the expression of SLC25A13 mRNA
CTD
PMID:19483382
NCBI chr 6:6,041,218...6,217,304
Ensembl chr 6:6,041,218...6,217,173
G
Slc25a3
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3
affects expression
ISO
Omeprazole affects the expression of SLC25A3 mRNA
CTD
PMID:19483382
NCBI chr10:90,952,436...90,959,902
Ensembl chr10:90,952,436...90,959,921
G
Slc27a2
solute carrier family 27 (fatty acid transporter), member 2
affects expression
ISO
Omeprazole affects the expression of SLC27A2 mRNA
CTD
PMID:19483382
NCBI chr 2:126,394,944...126,430,163
Ensembl chr 2:126,394,327...126,430,163
G
Slc39a8
solute carrier family 39 (metal ion transporter), member 8
affects expression
ISO
Omeprazole affects the expression of SLC39A8 mRNA
CTD
PMID:19483382
NCBI chr 3:135,522,644...135,594,333
Ensembl chr 3:135,531,040...135,594,333
G
Slc40a1
solute carrier family 40 (iron-regulated transporter), member 1
decreases expression
EXP
Omeprazole results in decreased expression of SLC40A1 protein
CTD
PMID:31669099
NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683
G
Slc46a1
solute carrier family 46, member 1
affects expression
ISO
Omeprazole affects the expression of SLC46A1 mRNA
CTD
PMID:19483382
NCBI chr11:78,356,527...78,362,771
Ensembl chr11:78,356,523...78,362,885
G
Slc66a2
solute carrier family 66 member 2
affects expression
ISO
Omeprazole affects the expression of SLC66A2 mRNA
CTD
PMID:19483382
NCBI chr18:80,298,458...80,335,940
Ensembl chr18:80,296,507...80,335,940
G
Slc6a6
solute carrier family 6 (neurotransmitter transporter, taurine), member 6
affects expression
ISO
Omeprazole affects the expression of SLC6A6 mRNA
CTD
PMID:19483382
NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047
G
Slco1a5
solute carrier organic anion transporter family, member 1a5
increases expression
ISO
Omeprazole results in increased expression of SLCO1A2 mRNA
CTD
PMID:19118567
NCBI chr 6:142,179,953...142,268,707
Ensembl chr 6:142,179,953...142,268,707
G
Sod1
superoxide dismutase 1, soluble
multiple interactions
EXP
Omeprazole inhibits the reaction [Ethanol results in decreased activity of SOD1 protein]
CTD
PMID:28849987
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sppl2a
signal peptide peptidase like 2A
affects expression
ISO
Omeprazole affects the expression of SPPL2A mRNA
CTD
PMID:19483382
NCBI chr 2:126,732,311...126,775,706
Ensembl chr 2:126,732,311...126,775,155
G
Srm
spermidine synthase
affects expression
ISO
Omeprazole affects the expression of SRM mRNA
CTD
PMID:19483382
NCBI chr 4:148,675,970...148,679,076
Ensembl chr 4:148,675,960...148,679,450
G
Srprb
signal recognition particle receptor, B subunit
affects expression
ISO
Omeprazole affects the expression of SRPRB mRNA
CTD
PMID:19483382
NCBI chr 9:103,065,232...103,079,264
Ensembl chr 9:103,065,231...103,079,336
G
Ssx2ip
SSX family member 2 interacting protein
affects expression
ISO
Omeprazole affects the expression of SSX2IP mRNA
CTD
PMID:19483382
NCBI chr 3:146,110,397...146,145,899
Ensembl chr 3:146,110,397...146,145,899
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
affects expression
ISO
Omeprazole affects the expression of ST3GAL6 mRNA
CTD
PMID:19483382
NCBI chr16:58,290,105...58,344,614
Ensembl chr16:58,288,488...58,344,606
G
St6gal1
beta galactoside alpha 2,6 sialyltransferase 1
affects expression
ISO
Omeprazole affects the expression of ST6GAL1 mRNA
CTD
PMID:19483382
NCBI chr16:23,043,478...23,179,100
Ensembl chr16:23,043,490...23,179,100
G
Suclg1
succinate-CoA ligase, GDP-forming, alpha subunit
affects expression
ISO
Omeprazole affects the expression of SUCLG1 mRNA
CTD
PMID:19483382
NCBI chr 6:73,225,488...73,253,890
Ensembl chr 6:73,225,365...73,253,894
G
Surf4
surfeit gene 4
affects expression
ISO
Omeprazole affects the expression of SURF4 mRNA
CTD
PMID:19483382
NCBI chr 2:26,810,052...26,823,801
Ensembl chr 2:26,810,052...26,823,940
G
Synj2bp
synaptojanin 2 binding protein
affects expression
ISO
Omeprazole affects the expression of SYNJ2BP mRNA
CTD
PMID:19483382
NCBI chr12:81,538,968...81,579,685
Ensembl chr12:81,544,715...81,579,685
G
Tacr1
tachykinin receptor 1
multiple interactions
EXP
Omeprazole inhibits the reaction [Acids affects the localization of TACR1 protein]
CTD
PMID:16091555
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Tgfb1
transforming growth factor, beta 1
increases expression
EXP
Omeprazole results in increased expression of TGFB1 protein
CTD
PMID:36243147
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfbi
transforming growth factor, beta induced
affects expression
ISO
Omeprazole affects the expression of TGFBI mRNA
CTD
PMID:19483382
NCBI chr13:56,757,399...56,787,172
Ensembl chr13:56,757,336...56,787,375
G
Thnsl2
threonine synthase-like 2 (bacterial)
affects expression
ISO
Omeprazole affects the expression of THNSL2 mRNA
CTD
PMID:19483382
NCBI chr 6:71,105,150...71,121,364
Ensembl chr 6:71,105,150...71,121,423
G
Timm21
translocase of inner mitochondrial membrane 21
affects expression
ISO
Omeprazole affects the expression of TIMM21 mRNA
CTD
PMID:19483382
NCBI chr18:84,964,316...84,970,168
Ensembl chr18:84,964,316...84,969,649
G
Timp2
tissue inhibitor of metalloproteinase 2
multiple interactions
ISO
Omeprazole inhibits the reaction [Indomethacin results in increased expression of TIMP2 protein]
CTD
PMID:16934674
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
G
Tkfc
triokinase, FMN cyclase
affects expression
ISO
Omeprazole affects the expression of TKFC mRNA
CTD
PMID:19483382
NCBI chr19:10,565,153...10,583,257
Ensembl chr19:10,565,155...10,583,018
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
Lipopolysaccharides inhibits the reaction [Omeprazole inhibits the reaction [Cisplatin results in increased expression of TLR4 protein]]; Omeprazole inhibits the reaction [Cisplatin results in increased expression of TLR4 protein]
CTD
PMID:32418911
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tmbim1
transmembrane BAX inhibitor motif containing 1
affects expression
ISO
Omeprazole affects the expression of TMBIM1 mRNA
CTD
PMID:19483382
NCBI chr 1:74,327,406...74,343,495
Ensembl chr 1:74,327,406...74,344,781
G
Tmco1
transmembrane and coiled-coil domains 1
affects expression
ISO
Omeprazole affects the expression of TMCO1 mRNA
CTD
PMID:19483382
NCBI chr 1:167,136,239...167,161,547
Ensembl chr 1:167,135,947...167,161,547
G
Tmed2
transmembrane p24 trafficking protein 2
affects expression
ISO
Omeprazole affects the expression of TMED2 mRNA
CTD
PMID:19483382
NCBI chr 5:124,678,835...124,688,566
Ensembl chr 5:124,678,758...124,688,569
G
Tmed7
transmembrane p24 trafficking protein 7
affects expression
ISO
Omeprazole affects the expression of TMED7 mRNA
CTD
PMID:19483382
NCBI chr18:46,718,995...46,730,602
Ensembl chr18:46,693,302...46,730,602
G
Tmem123
transmembrane protein 123
affects expression
ISO
Omeprazole affects the expression of TMEM123 mRNA
CTD
PMID:19483382
NCBI chr 9:7,764,078...7,794,334
Ensembl chr 9:7,764,042...7,794,334
G
Tmem97
transmembrane protein 97
affects expression
ISO
Omeprazole affects the expression of TMEM97 mRNA
CTD
PMID:19483382
NCBI chr11:78,432,643...78,441,561
Ensembl chr11:78,432,643...78,441,603
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
Omeprazole inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] Omeprazole inhibits the reaction [Cisplatin results in increased expression of TNF protein]; Omeprazole inhibits the reaction [Ethanol results in decreased expression of TNF protein] Omeprazole inhibits the reaction [Ethanol results in increased expression of TNF protein]
CTD
PMID:19232345 PMID:25637687 PMID:26970604 PMID:30452898 PMID:32418911
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Txn1
thioredoxin 1
affects expression
ISO
Omeprazole affects the expression of TXN1 mRNA
CTD
PMID:19483382
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
G
Txnl1
thioredoxin-like 1
affects expression
ISO
Omeprazole affects the expression of TXNL1 mRNA
CTD
PMID:19483382
NCBI chr18:63,795,872...63,825,535
Ensembl chr18:63,794,165...63,841,872
G
Tyr
tyrosinase
multiple interactions decreases expression
ISO EXP
Omeprazole affects the N-linked glycosylation of and results in increased degradation of TYR protein; Omeprazole inhibits the reaction [ATP7A protein results in increased activity of TYR protein] Omeprazole results in decreased expression of TYR protein
CTD
PMID:25337692
NCBI chr 7:87,073,979...87,142,637
Ensembl chr 7:87,073,979...87,142,720
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
affects expression
ISO
Omeprazole affects the expression of UBA52 mRNA
CTD
PMID:19483382
NCBI chr 8:70,960,913...70,963,067
Ensembl chr 8:70,960,913...70,963,451
G
Ube2n
ubiquitin-conjugating enzyme E2N
affects expression
ISO
Omeprazole affects the expression of UBE2N mRNA
CTD
PMID:19483382
NCBI chr10:95,351,024...95,381,520
Ensembl chr10:95,351,007...95,381,519
G
Ufd1
ubiquitin recognition factor in ER-associated degradation 1
affects expression
ISO
Omeprazole affects the expression of UFD1 mRNA
CTD
PMID:19483382
NCBI chr16:18,630,486...18,654,011
Ensembl chr16:18,630,529...18,654,011
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases expression affects expression
ISO
Omeprazole results in increased expression of UGT1A1 mRNA Omeprazole affects the expression of UGT1A1 mRNA
CTD
PMID:19118567 PMID:19483382 PMID:25626140
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt1a10
UDP glycosyltransferase 1 family, polypeptide A10
increases expression
ISO
Omeprazole results in increased expression of UGT1A10 mRNA
CTD
PMID:19118567
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases expression
ISO
Omeprazole results in increased expression of UGT1A2 mRNA; Omeprazole results in increased expression of UGT1A3 mRNA
CTD
PMID:19118567
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
G
Ugt1a5
UDP glucuronosyltransferase 1 family, polypeptide A5
increases expression
ISO
Omeprazole results in increased expression of UGT1A4 mRNA
CTD
PMID:19118567
NCBI chr 1:88,093,734...88,147,724
Ensembl chr 1:88,093,734...88,146,719
G
Ugt1a6b
UDP glucuronosyltransferase 1 family, polypeptide A6B
increases expression multiple interactions
ISO
Omeprazole results in increased expression of UGT1A6 mRNA [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of UGT1A6 mRNA
CTD
PMID:19118567 PMID:22687989
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
G
Ugt1a9
UDP glucuronosyltransferase 1 family, polypeptide A9
increases expression
ISO
Omeprazole results in increased expression of UGT1A9 mRNA
CTD
PMID:19118567
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
ISO
Omeprazole results in increased expression of UGT2B1 mRNA
CTD
PMID:25626140
NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
G
Uqcr11
ubiquinol-cytochrome c reductase, complex III subunit XI
affects expression
ISO
Omeprazole affects the expression of UQCR11 mRNA
CTD
PMID:19483382
NCBI chr10:80,238,831...80,242,655
Ensembl chr10:80,238,831...80,242,664
G
Vnn1
vanin 1
affects expression
ISO
Omeprazole affects the expression of VNN1 mRNA
CTD
PMID:19483382
NCBI chr10:23,770,586...23,781,242
Ensembl chr10:23,770,586...23,781,241
G
Wdr26
WD repeat domain 26
affects expression
ISO
Omeprazole affects the expression of WDR26 mRNA
CTD
PMID:19483382
NCBI chr 1:181,000,791...181,046,211
Ensembl chr 1:181,000,793...181,039,566
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
affects expression
ISO
Omeprazole affects the expression of YWHAG mRNA
CTD
PMID:19483382
NCBI chr 5:135,937,233...135,963,495
Ensembl chr 5:135,937,263...135,963,470
G
Zdhhc23
zinc finger, DHHC domain containing 23
affects expression
ISO
Omeprazole affects the expression of ZDHHC23 mRNA
CTD
PMID:19483382
NCBI chr16:43,785,396...43,800,295
Ensembl chr16:43,785,396...43,800,154
G
Zp3r
zona pellucida 3 receptor
decreases expression affects expression
ISO
Omeprazole results in decreased expression of C4BPA mRNA Omeprazole affects the expression of C4BPA mRNA
CTD
PMID:19483382 PMID:25626140
NCBI chr 1:130,474,847...130,557,371
Ensembl chr 1:130,504,450...130,557,358
G
Zwint
ZW10 interactor
affects expression
ISO
Omeprazole affects the expression of ZWINT mRNA
CTD
PMID:19483382
NCBI chr10:72,490,678...72,510,796
Ensembl chr10:72,490,677...72,510,796
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
5-hydroxymethylomeprazole results in increased expression of CYP1A1 protein
CTD
PMID:10103034
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp2c37
cytochrome P450, family 2. subfamily c, polypeptide 37
multiple interactions
EXP
[CYP2C37 protein results in increased metabolism of Omeprazole] which results in increased chemical synthesis of 5-hydroxymethylomeprazole
CTD
PMID:30503582
NCBI chr19:39,980,868...40,000,687
Ensembl chr19:39,980,868...40,000,687
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all